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 ABSTRACT 
 
Protein-protein interactions play a central role in most biological processes. One such biological 
process is the maintenance of a reducing environment inside the cell. To maintain an internal 
reducing environment, living cells have evolved two enzymatic systems (glutathione and 
thioredoxin (Trx) systems). The Trx system is composed of the enzyme TrxR and its substrate 
Trx. The two proteins constitute an important thiol-dependent redox system that catalyzes the 
reduction of many proteins that are responsible for a variety of cellular functions. The system 
relies on transient protein-protein interactions between Trx and TrxR for its function.  
Cross-reactivity of components of the Trx system between species has been shown to be 
medically relevant. For example, Helicobacter pylori Trx (HP Trx) is thought to mediate 
catalytic reduction of human immunoglobulins and thus facilitate immune evasion.  It has also 
been proposed that Helicobacter pylori gains access to the impenetrable gastric mucous layer by 
using secreted HP Trx to reduce the disulfide bonds present in the cysteine-rich mucin regions 
that are responsible for cross-linking mucin monomers. Therefore, disruption of secreted HP 
Trx-host protein interaction may result in restoration of the viscoelastic and hydrophobic 
protective properties of mucus. Previous studies aimed at understanding the nature of cross-
reactivity of Trx system components among various species have shown that Trxs have higher 
affinity for cognate TrxRs (same species), than for TrxRs from different species. However, the 
basis for this specificity is not known. A growing body of evidence suggests that most protein-
protein interactions are mediated by a small number of protein-protein interface residues, 
referred to as “hot spot” residues or binding epitopes. Therefore, understanding the biochemical 
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basis of the affinity of proteins for their partners usually begins by identifying the hot spot 
residues responsible for the protein complex interactions.  
In this study, the crystal structures of Deinococcus radiodurans thioredoxin reductase (DR TrxR) 
and Helicobacter pylori TrxR (HP TrxR) were determined at 1.9 Å and 2.4 Å respectively.  
Analysis of the Trx-binding sites of both structures suggests that the basis of affinity and 
specificity of Trx for TrxR is primarily due to the shape rather than the charge of the surface.  In 
addition, the complex between Escherichia coli thioredoxin reductase (EC TrxR) and its 
substrate thioredoxin (EC Trx) was used to identify residues that are responsible for TrxR-Trx 
interface stability. Using computational alanine scanning mutagenesis and visual inspection of 
the EC TrxR-Trx interface, 22 EC TrxR side chains were shown to make contact across the 
TrxR-Trx interface. Although more than 20 EC TrxR side chains make contact across the TrxR-
Trx interface, our results suggest that only 4 residues (F81, R130, F141, and F142) account for 
the majority of the EC TrxR-Trx interface stability. Individual replacement of equivalent DR 
TrxR residues (M84, K137, F148, F149) with alanine resulted in drastic changes in binding 
affinity, confirming that the four residues account for most of TrxR-Trx interface stability. These 
hot spot residues are surrounded by less important residues (hydrophobic and hydrophilic) that 
are also predicted to contribute to interface stability. F148 and F149 are invariant across bacterial 
TrxRs, however other residues that contact Trx are less conserved including M84 and K137. 
When M84 and K137 were changed to match equivalent E. coli TrxR residues (K137R, M84F); 
D. radiodurans TrxR substrate specificity was altered from its own Trx to that of E. coli Trx. 
The results suggest that a small subset of the TrxR-Trx interface residues are responsible for the 
majority of Trx binding affinity and specificity, a property that has been shown to general to 
protein-protein interfaces. 
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CHAPTER ONE: INTRODUCTION 
1.1 PROTEIN­PROTEIN INTERACTIONS 
 
Protein-protein interactions play a key role in all cellular processes; therefore, understanding 
how proteins interact with each other is the subject of intense research (Moreira et al, 2007). 
Protein-protein interactions can be broadly classified permanent or transient (Devos & Russell, 
2007). Permanent protein-protein complexes facilitate transport (e.g. the nuclear pore), 
transcription (e.g. RNA polymerases), translation (e.g. the ribosome), metabolism (e.g. glutamine 
synthetase), signaling (e.g. G-protein complexes in eukaryotes) (Devos & Russell, 2007). 
Transient protein-protein interactions are also important in many biological processes including 
signal transduction (e.g. hormone-receptor), gene transcription (e.g. Thioredoxin (Trx)-
transcription factors), DNA synthesis (e.g. Trx-ribonucleotide reductase) and regulation of the 
redox status of the cell (e.g. Thioredoxin-thioredoxin peroxidase (Trx-Tpx)) (Clackson & Wells, 
1995; Lo Conte et al, 1999; Mustacich & Powis, 2000). Non-physiological protein-protein 
interactions such as crystal contacts (protein crystallization) can also be considered as transient 
protein-protein interactions because, such interactions are non-specific low affinity interactions 
(Carugo & Argos, 1997). 
Typical protein- protein interfaces are usually about 1600 Å2 (~800 Å2 per monomer). Contacts 
at protein-protein interfaces can be of any type: covalent (disulfides), hydrophobic, electrostatic, 
or hydrogen bonding (Lo Conte et al, 1999). These contacts can be mediated by side-chain or 
main-chain interactions (Jackson, 1999). Those interactions that are mediated by side chains tend 
to have 10 or more side chains that make contact across the interface (Janin & Chothia, 1990; 
Sheinerman et al, 2000).  Unlike folded proteins which are hydrophobic at the core and 
1 
 
  
hydrophilic at the surface, protein-protein interfaces tend to have both hydrophobic and 
hydrophilic residues at the interface (Sheinerman et al, 2000). Although the general principles 
guiding protein-protein interactions are common to permanent and transient protein-protein 
interfaces, there are some differences between permanent and transient protein-protein 
interactions. In general, transient protein-protein interfaces tend to have less van der Waals 
surfaces complimentarity compared to permanent protein-protein interfaces (Jones & Thornton, 
1996). In addition, permanent protein-protein interfaces tend to be more hydrophobic than 
transient protein-protein interfaces, because each partner of transient protein-protein complexes 
exists independently most of the time (binding surfaces exposed to solvent most of the time) 
(Jones & Thornton, 1996).  
The basic physical principles (thermodynamics) that govern protein-protein interactions are 
similar to those that govern protein folding. Therefore, the affinity of two uncomplexed proteins 
that form a noncovalent complex is determined by the change in enthalpy and entropy of the 
system. Specific interactions (hydrogen bonding, electrostatic and van der Waals forces) and 
non-specific effects (the hydrophobic effect and conformational entropy) are used to describe the 
process of complexation (Ajay & Murcko, 1995; Bogan & Thorn, 1998). The protein-protein 
interaction system consists of the protein molecules and solvent before complex formation, and 
the complex and solvent after complexation (Ajay & Murcko, 1995). Upon complexation there is 
a gain in entropy due to reorganization of solvent molecules (expulsion of water molecules from 
hydrophobic interface residues), a loss in entropy due to association (loss of translational and 
conformational freedom), and a decrease in enthalpy due to protein-protein interactions 
(hydrogen bonding, electrostatic and van der Waals forces). Although there is some loss of 
entropy due to association, the overall process of complexation is spontaneous because of solvent 
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reorganization and enthalpic changes due to protein-protein interactions (Bogan & Thorn, 1998; 
Moreira et al, 2007). 
Because most cellular functions involve protein-protein interactions, aberrant protein-protein 
interactions often result in disease. Examples of diseases caused by aberrant protein-protein 
interactions include cancer (Rudolph, 2007), Parkinson’s disease (Suzuki, 2006) and 
Huntington’s disease (Horn et al, 2006). Therefore, disrupting aberrant protein-protein 
interactions offers a huge therapeutic potential. However, discovering small molecules that can 
disrupt protein-protein interactions is considered a major challenge for many reasons (Che et al, 
2006; Wells & McClendon, 2007). Protein-protein interactions typically occur over a large 
surface area (about 800 Å2 per monomer) and involve amino acid residues that are not 
contiguous in the polymer chain. Eight hundred Å2 is a much larger surface area than a small 
molecule can cover (typically 200 Å2). In addition, the binding surfaces at protein-protein 
interfaces tend to be relatively flat, often lacking crevices and pockets that provide snug binding 
sites for small molecules (Che et al, 2006; Wells & McClendon, 2007). Recent success stories, 
however, suggest that disrupting protein–protein interfaces might be more tractable than had 
been previously thought. For example, small molecules have been identified that disrupt some 
protein-protein interactions: human protein double minute 2-tumor suppressor protein p53 
(Vassilev et al, 2004), human papilloma virus transcription factor E2-viral helicase E1 (Wang et 
al, 2004), and tumor necrosis factor-tumor necrosis factor receptor 1 (He et al, 2005).  
An important observation from a careful analysis of protein-protein interfaces is that most of the 
binding energy at protein-protein interfaces is due to a few ‘hot spot’ residues (functional 
epitope) rather than all of the interface residues. This phenomenon was first observed by analysis 
of free energy changes upon mutation to alanine at the interface of human growth hormone and 
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its receptor (Clackson & Wells, 1995). Hot spot residues have since been observed in several 
protein-protein complexes (Bogan & Thorn, 1998; Moreira et al, 2007). Although there is no 
universal definition of hot spot residues, they have been defined as those sites where alanine 
mutations cause a 1 kcal (Kortemme & Baker, 2002) or 2 kcal (Moreira et al, 2007) increase in 
free energy (∆G). Since most of the binding affinity at protein-protein interfaces is due to a small 
subset of interface residues (binding “hot spots” that are usually clustered at the center of the 
protein-protein interface), it is not necessary for a small molecule to cover the entire protein-
protein interface. A small molecule that maintains the three-dimensional arrangement of the hot 
spot residues can disrupt protein-protein interactions because it retains the features that confer 
affinity to protein-protein interfaces. Binding hot spots thus provide a rational basis for design of 
small molecule inhibitors (“protein-surface mimetics”) of protein-protein interactions. As a 
result, the first step towards protein-surface mimetics is usually to identify hot spot residues 
responsible for protein complex recognition (Che et al, 2006; Wells & McClendon, 2007). 
A systematic analysis of hot spot residues reveals that their distribution is non-random i.e. certain 
amino acids (Y, W, and R) have a higher propensity than other amino acids for the interface, and 
that they tend to cluster at the centre of the interface rather on the edges (Moreira et al, 2007). It 
was further observed that hot spot residues were sheltered from bulk solvent. However, many 
other interface residues that are occluded from solvent are not hot spot residues, i.e. occlusion of 
solvent was necessary but not a sufficient determinant of hot spot residues. Indeed a survey of 
interface residues showed that the amount of change of total side-chain solvent-accessible 
surface area (∆ASA) on complex formation is a poor predictor of hot spot residues because other 
factors such as complementarity of van der Waals surfaces contribute to interface stability 
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(Bogan & Thorn, 1998; Moreira et al, 2007). These observations led to the proposal of the O-
ring hypothesis as the basis of the hot spot residue phenomenon (Bogan & Thorn, 1998). 
The O-ring hypothesis suggests that hot spot residues are surrounded by energetically less 
important residues, whose role is to occlude bulk solvent from hot spot residues. Occluding 
solvent from hot spot residues generates suitable dielectric constant and solvation conditions for 
a hot spot of interaction energy i.e. a lower effective dielectric constant increases the interaction 
strength of electrostatic and hydrogen bonding interactions (Bogan & Thorn, 1998). The O-ring 
phenomenon may explain the observed interface amino acid propensities. Y, W, and R are the 
most common amino acids at the interface, because they are capable of hydrogen bonding and 
hydrophobic interactions. The O-ring hypothesis is now widely accepted, although there is no 
conclusive evidence for it. The assumption that non-hot-spot residues do not participate in 
important interactions is only valid if it can be demonstrated that there are no secondary effects 
upon mutation to alanine including conformational changes of side chains, movement of the 
protein backbone, and reorganization of solvent structure near mutation sites that can 
compensate for loss of side chain interactions (Moreira et al, 2007; Sanders, 1998). 
1.2 THIOREDOXIN SYSTEM 
1.2.1 General Background 
 
Proteins in the extracellular environment are rich in stabilizing disulfides, made possible by 
oxidizing conditions in the extracellular environment. In contrast, most proteins inside the cell 
contain free sulfhydryl groups, due to the reducing environment inside the cell. The Trx system 
is one of the two major systems responsible for maintaining a reducing environment inside the 
cell; the other is the glutathione reductase system (Arner & Holmgren, 2000).  All aerobic 
organisms generate reactive oxygen species (ROS) during normal cell function through 
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processes such as respiration, or in response to various stimuli such as Ultra-violet (UV) 
irradiation and chemical carcinogens. However, excessive production of ROS can damage 
cellular macromolecules like DNA and proteins. Therefore, living cells have evolved various 
enzymatic systems that scavenge ROS. Thioredoxin-thioredoxin dependent peroxidase (Trx-
Tpx) is one such enzymatic system. The Trx system thus plays an essential role in maintaining 
the integrity of cells (Adler et al, 1999; Nordberg & Arner, 2001). Indeed, gene knock out studies 
have shown that the Trx system is essential for the viability of some organisms (Krnajski et al, 
2002). 
The system is composed of Trx and the associated enzyme thioredoxin reductase (TrxR). It is 
found universally in both prokaryotes and eukaryotes. TrxR catalyzes the transfer of reducing 
equivalents from NADPH to Trx via a permanently bound FAD and an active site disulfide 
(Mustacich & Powis, 2000). Electrons are transferred to FAD from NADPH, then from FAD to 
the active-site disulfide (Figure 1.1) and finally from TrxR to Trx (Figure 1.2). Trx in turn 
reduces other proteins such as Tpx and ribonucleotide reductase (Lennon & Williams, 1996; 
Mustacich & Powis, 2000).  
There are two distinct forms of this enzyme; low molecular weight thioredoxin reductase (LMW 
TrxR) (35 kDa) found in prokaryotes and some eukaryotes, and high molecular weight 
thioredoxin reductase (HMW TrxR) (55 kDa) found in eukaryotes. The two types of TrxR have 
some differences in structure and mechanism. The structure and mechanism of HMW TrxR has 
been described in several publications (Zhon et al, 1998; Zhong et al, 2000). Only LMW TrxRs 
were of interest to this project. In HMW TrxR, NADPH binds in close proximity to the 
isoalloxazine ring of FAD, allowing electrons to flow from NADPH to active-site disulfide via 
the isoalloxazine ring of FAD without a major conformational change in the enzyme (Zhong et 
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al, 2000). In contrast, the LMW TrxR’s FAD domain is too far in space from the NADPH 
domain for electron transfer to occur. It was postulated and later confirmed by the Escherichia 
coli thioredoxin reductase-thioredoxin (EC TrxR- EC Trx) complex structure that during 
catalysis the NADPH domain rotates 67º while the FAD domain remains fixed, bringing the 
NADPH domain close to the FAD domain in order for electron transfer to take place (Lennon et 
al, 2000). Electron transfer then occurs from NADPH to FAD and finally to the active site 
disulfide. The enzymatic reaction scheme for the LMW Trx system (Lennon & Williams, 1996) 
is shown in Figure 1.1 and Figure 1.2. 
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Figure 1.1: Movement of reducing equivalents from NADPH to the active site disulfide of TrxR 
via FADH2 
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Figure 1.2: Schematic representation of TrxR conformation during catalysis; flavin oxidizing 
(FO) conformation (Blue) and flavin reducing (FR) conformation (Pink) (Lennon & Williams, 
1996). Catalysis of TrxR is accompanied by rotation events and cycling between a two electron 
and a four electron reduced state of the enzyme. 
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1.2.2 Structure of Trx 
 
Trx is a relatively small and ubiquitous protein with a molecular weight of about 12 kDa. It 
contains a highly conserved active site motif WCGPC. The Trx structure consists of the “Trx 
fold”, so-named because it was first identified in Trx (Martin et al, 1993). The Trx fold family 
includes: glutaredoxin (Bushweller et al, 1994), DsbA (Martin et al, 1993), protein disulfide 
isomerase (Lundström & Holmgren, 1993), and glutathione peroxidase (Epp et al, 1983). All 
these proteins are involved in thiol chemistry. The thioredoxin fold consists of a five-stranded 
beta sheet forming a hydrophobic core surrounded by three or four alpha helices (Figure 1.3). 
The secondary structural elements of the Trx fold can be subdivided into an N-terminal βαβ 
motif and a C-terminal ββα motif, connected by a loop of residues that incorporates a third helix 
(Figure 1.3). The quaternary structure of Trx varies from species to species, however the tertiary 
structure is highly conserved across various species. Most thioredoxins are monomers in 
solution, but human thioredoxin forms a homodimer linked by a disulfide (Weichsel et al, 1996). 
 
Figure 1.3: Structure of E. coli Trx (PDB code: 1F6M), showing the N-terminal βαβ motif 
(pink), a C-terminal ββα motif (cyan), and a third helix (green). This figure was generated using 
PyMol (DeLano, 2002a) 
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1.2.3 Structure of TrxR 
 
TrxR is a homodimeric enzyme with a highly conserved active site motif CATC.  Each monomer 
consists of an FAD-binding domain and an NADPH-binding domain (Figure 1.4). Both the 
NADPH-binding and the FAD-binding domains contain variants of the canonical nucleotide 
binding fold that was first seen in glutathione reductase (Schulz et al, 1978). Each domain 
contains two β-sheets (one parallel and the other anti-parallel β-sheet) and three α-helices. The 
two domains are connected by two β-strands and loops, but otherwise separated by a large cleft 
which is mostly filled with water molecules (Figure 1.4). 
 
 
Figure 1.4: Structure of LMW TrxR. Overall structure of the A chain of DR TrxR (PDB code: 
2Q7V) in the FO conformation. In this conformation, the FAD-binding domain is too far from 
the NADPH-binding domain for electron transfer to occur from NADPH to FAD. A 67° rotation 
by the NADPH-binding domain brings NADPH close to FAD, allowing electron transfer to 
occur from NADPH to FAD (Kuriyan et al, 1991). 
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1.2.4 Conformational States of TrxR 
 
The first TrxR structure solved was from E. coli (Kuriyan et al, 1991). A surprising finding from 
the structure was that there was no direct path for the flow of electrons to the active-site disulfide 
from NADPH via FAD. The NADPH domain was too far (17 Å) from the FAD domain for 
electron transfer to occur. Moreover, the structure revealed that the active site disulfide is buried 
and is unavailable for reaction with Trx. This led to the proposal that the enzyme undergoes large 
conformational changes during catalysis. A 67º rotation places the FAD domain close to the 
NADPH domain, a favorable position for electron transfer to occur, and exposes the active site 
thiols for reaction with Trx. A rotation back to the original conformation is then needed for 
electron transfer to occur from the reduced FAD to the active site disulfide (Figure 1.5). A 
nomenclature has been suggested (Mulrooney & Williams, 1997) for the two conformations; 
flavin oxidizing (FO), for the conformation in which the active site disulfide is close to and can 
oxidize the flavin and flavin reducing (FR) for the conformation in which the active site dithiol is 
exposed to solvent and NADPH is close to and can reduce the flavin, during catalysis. It is worth 
emphasizing that the two conformations differ in the domain arrangement rather than in the 
redox state of the flavin (Figure 1.5). It has been shown that the two conformations are in 
equilibrium in solution, but the FR conformation is greatly favored in solution (Mulrooney & 
Williams, 1997). However, all TrxR crystal structures deposited in the PDB are in the FO 
conformation, thus it can be inferred that the FO conformation predominates the crystalline state. 
The reason for this is not clear as the “trigger” for rotation is not known (Mulrooney & Williams, 
1997). 
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Figure 1.5: Schematic representation of the FO and FR conformations of TrxR. TrxR undergoes 
a large conformational change during catalysis. From the FO conformation (blue) where the 
active site disulfide is adjacent to FAD to the FR conformation (red) where NADPH is adjacent 
to FAD. 
 
 
Using TrxR and Trx mutants in which one of the active site cysteine residues had been altered to 
serine in both TrxR and Trx, a complex between TrxR and Trx was successfully formed (Figure 
3.24) (Wang et al, 1996). The two proteins were linked by a disulfide bond between their 
respective remaining single cysteine active-site residues.  Based on the proposed FO/FR model, 
the TrxR-Trx complex is expected to restrict TrxR to the FR conformation, because the FR 
conformation is the only one in which the active-site thiol is exposed to the protein surface and 
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can react with Trx. Because of the large size of Trx, it is expected that Trx will stay “trapped” in 
the FR conformation (Mulrooney & Williams, 1997; Wang et al, 1996). Indeed, when the crystal 
structure of TrxR-Trx complex was later solved, it was found that TrxR was in the FR 
conformation when complexed with Trx (Lennon et al, 2000). Therefore, crystal structures of 
both conformational states have been observed for this enzyme (Figure 1.6): the reduced flavin 
conformation (FR) conformation (Lennon et al, 2000) and the oxidized flavin (FO) conformation 
(Waksman et al, 1994). 
 
 
 
Figure 1.6 A: The structure of the FO conformation of TrxR. In the FO conformation, the 
NADPH domain is too far from the FAD domain (~17Å) for electron transfer to occur from 
NADPH to FAD. The figure was generated using HP TrxR structure (PDB code: 2QOK). 
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Figure 1.6 B: The structure of FR conformation of TrxR. In the FR conformation, the NADPH 
domain is close to the FAD domain. Electron transfer can occur from NADPH to FAD. The 
figure was generated using EC TrxR structure (PDB code: 2F6M). 
 
Fluorescence spectroscopy has been used to study the equilibrium between the two 
conformations in solution (Mulrooney & Williams, 1997). It was observed that the EC TrxR 
active site mutant C138S had much less flavin fluorescence (7%) compared to the wild type 
enzyme (Mulrooney & Williams, 1997). Using this observation Mulrooney and Williams 
reasoned that flavin fluorescence could be used to study the conformational equilibrium of TrxR 
in solution. They performed a series of experiments that demonstrated that the two TrxR 
conformations are in equilibrium in solution, and that the FO conformation is predominant in the 
C138S mutant and the FR conformation is predominant in the wild type. The large reduction in 
flavin fluorescence seen in the C138S mutant is presumably because of quenching by a hydrogen 
bond between the serine at 138 and the N5 of the flavin (Mulrooney & Williams, 1997).  This 
interaction would only be possible in the FO conformation (Figure 1.7; the disulfide is close to 
the flavin); therefore it can be concluded that the C138S mutant mostly exists in FO 
conformation in solution. The residual fluorescence seen is probably due to the smaller 
population of the FR conformation in the C138S mutant. 
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Figure 1.7: Position of the active site disulfide relative to the isoalloxazine ring of FAD. 
Replacement of the disulfide with a serine residue (EC TrxR C138S mutant) results in quenching 
by a hydrogen bond between serine 138 and the N5 of the flavin. 
 
 
Titration of the thiol specific reagent phenyl mercuric acetate (PMA) with the C138S mutant 
results in a large linear increase of fluorescence which saturates at 1:1 ratio of PMA:C138S, 
demonstrating that the equilibrium can be altered by binding of the bulk reagents to TrxR active 
site thiols, and that the change can be monitored by fluorescence. To observe the FR 
conformation, Mulrooney and Williams (1997), titrated a non-reducing NADPH analog 3-
aminopyridine adenine dinucleotide phosphate (AADP+) against the wild type enzyme, PMA 
treated C138S mutant, and untreated C138S mutant. They observed flavin fluorescence 
quenching and a shift in AADP+ absorbance maxima in the PMA treated C138S mutant and the 
wild type enzyme, but not the untreated C138S. These results are consistent with AADP+ analog 
binding near the FAD in the FR conformation. Therefore it can be concluded that the wild type 
enzyme exists predominantly in the FR conformation in solution (Mulrooney & Williams, 1997; 
Van den Berg et al, 2001). 
15 
 
  
1.3 CHARACTERIZATION OF PROTEIN­PROTEIN INTERACTIONS 
1.3.1 Enzyme Kinetics 
 
Enzymes are biological catalysts that increase the rate of chemical reactions without undergoing 
any permanent changes. They increase reaction rates by providing an alternative lower energy 
pathway for conversion of substrate to product. Enzymes can increase the rate of the reactions by 
as much as 1017 fold. The basis of their catalytic power is in their ability to generate various 
localized chemical environments around the same substrate, to bring two substrates to close 
proximity for reactions to occur, and to form highly reactive covalent intermediates (Price and 
Stevens, 1999). A simple general scheme for a single substrate enzymatic reaction is shown 
below: 
 
 
k2k1
k-1  
 
Usually enzyme reaction rates are measured after a reaction has partially progressed (small 
percentage) towards the product (initial rates) and, they exhibit saturation at high substrate 
concentrations. The equation describing enzyme kinetics was derived by making one of two 
assumptions (apart from the general assumptions that there is no product inhibition, no 
cooperativity, and the enzyme concentration stays constant throughout the reaction): 
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(i) The E + S  ES equilibrium is only slightly disturbed by breakdown of 
ES to give product (Michaelis-Menten) 
e) 
or 
(ii) ES remains in a steady state during the reaction (Briggs-Haldan
According to the steady-state assumption the rate of production of ES (k1[E][S]) must equal the 
rate of breakdown (k-1[ES] + k2[ES]) 
Therefore: k1[E][S] = k-1[ES] + k2[ES] 
Making [ES] the subject of the formula: 
 
[ES] =     k1[E][S]  = [E][S]K where K =  k1 
                      k-1 + k2                                                        k-1 + k2 
 
The fraction of enzyme available as ES, at any concentration can be given as: 
 F =    [ES]  
                   [E] + [ES]    (1) 
 
Therefore: 
 
F =       K [E][S]      =             K[E] ([S]) 
             [E] + K[E][S]                K[E] (1/K + [S])    
 
where 1/K = k-1 + k2 = Km 
             k1 
 
F=   [S] 
                      Km + [S]        (2) 
 
 
If the total concentration of enzyme is [E]0, then 
 
[ES] = F [E]0 =      [E]0 [S] 
                                        Km + [S]     (3) 
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The rate of product formation is given by: 
 
v = k2 [ES] =        k2[E]0 [S] 
                                        Km + [S]    (4) 
 
Putting k2[E]0 = Vmax then 
 
v =      Vmax [S]           (Michaelis-Menten equation) 
                                                 Km + [S]    (5) 
 
Plotting the Michaelis-Menten equation shows that v will tend towards a maximum value (Vmax) 
as the value of [S] increases (Figure 1.8). k2 is known as the kcat or the turnover number; it 
represents the number of substrate molecules converted into product per unit time. Km is the 
Michaelis constant. It may contain more than k1, k-1, and k2, since more than one central complex 
might exist in the course of the reaction. When substrate concentration ([S]) equals the Km, the 
Michaelis-Menten equation simplifies to v = 0.5Vmax. For a Michaelis-Menten reaction, k2 is rate-
limiting; therefore k2 << k-1 and Km reduces to k-1/k1, which is the dissociation constant for the ES 
complex. When these conditions hold (k2 << k-1), Km can be used to describe the affinity of 
various substrates for the enzyme (Price & Stevens, 1999).   
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Figure 1.8: A Machaelis-Menten plot. A plot of substrate concentration vs initial velocity for a 
reaction obeying Michaelis-Menten kinetics 
                                                                                                                                                                                    
1.3.2 Protein­Protein Docking 
 
Many biological processes depend on specific recognition of one or more proteins by partner 
proteins (complexation). Examples of protein-protein complexes include: enzyme/inhibitor, 
antibody/antigen, hormone/hormone receptor, and protein kinase/substrate. Experimental 
structure determination of protein-protein complexes (primarily by x-ray crystallography and 
NMR spectroscopy) provides an important tool for characterization of the nature and 
composition of the interfaces of protein-protein complexes. However, determination of protein 
complex structures remains difficult, as a result only a few (less than 1 % of the structures 
deposited in the PDB) hetero-multimeric protein-protein complexes have been solved  (Chen & 
Weng, 2002; Janin, 2007). Computational approaches have previously been used to predict 
protein-protein complexes formed from two or more free partners. The accuracy of various 
prediction algorithms is evaluated biennially through community-wide blind prediction 
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experiments (Critical Assessments of Predicted Interactions (CAPRI)). The degree of success of 
the computational predictions depends on the amount of conformational change upon 
complexation, with those complexes showing a small amount of change upon complexation 
having the highest success (greater than 60% of interface interactions correctly predicted) (Janin, 
2007). Two computational approaches are used to model protein-protein interactions (docking 
and binding simulations). Docking approaches, unlike binding simulations, are not concerned 
with modeling of binding pathways, but rather focus on the final configuration of the complex 
(Vakser & Kundrotas, 2008).  
Docking approaches involve two elements: a scoring function and a search algorithm. The role 
of the scoring function is to distinguish between nearly correct and incorrect complexes. The 
scoring function can be built from empirical knowledge-based data or fundamental physics-
based principles. The knowledge-based scoring functions are derived from statistical analysis of 
biological data bases. These are expressed as potentials that empirically reproduce the 
fundamental structural properties of proteins. Physics-based methods use energy terms that 
describe specific interactions between atoms (e.g. covalent bonds, electrostatics, van der Waals 
and hydrogen bonds) to rank protein-protein complexes (Lee and Lee, 2008). Search algorithms 
can perform a full solution space search or a guided search that explores only a part of the 
solution space. Global (full space) searches are typically performed by Fast Fourier Transform 
methods that perform rigid-body searches i.e. without any flexibility considerations. Some 
algorithms (e.g. ZDOCK) allow incorporation of known biological information, e.g. predicted 
interface residues, which simplifies the global search process (Lee and Lee, 2008).  
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1.4. OVERVIEW OF PROTEIN CRYSTALLOGRAPHY 
1.4.1 Protein Crystal Growth 
 
A protein crystal consists of a large number of three-dimensionally arranged repeating units, the 
unit cell. Each unit cell contains one or more protein molecules whose position and orientation in 
each unit cell is determined by the space group symmetry. Protein crystal growth can be thought 
of as a reversible equilibrium process, with molecules entering and leaving the solid phase. At 
the saturation point, there is no net change in molecules entering and leaving the solid phase. To 
form crystals it is necessary to achieve supersaturation, where the equilibrium is shifted to favor 
the solid state. Crystal growth occurs in three stages: nucleation, growth and cessation of growth. 
In the nucleation stage a “critical nucleus” must be formed; anything smaller will redissolve. The 
critical nucleus initiates aggregation in an ordered manner leading to the formation and growth of 
crystals. There has been only limited research done on cessation of growth, as a result, it is not a 
well-understood process. There are two possible reasons for cessation of growth: a drop in 
saturation level as crystals form, and/or inhibition of growth by surface defects (McPherson, 
1999). A two dimensional solubility phase diagram can be used to visualize the process of crystal 
growth (Figure 1.9). The solubility curve divides the concentration space into undersaturation 
and supersaturation regions. The supersaturation region is sub-divided into three zones: 
metastable zone, nucleation zone, and precipitation zone. Proteins will never crystallize in the 
undersaturation zone. In the precipitation zone excess protein exists as amorphous precipitate 
instead of remaining in solution. As the name suggests, nucleation occurs in the nucleation zone; 
crystal growth can also occur in this zone. The metastable region is ideal for growth of few large 
crystals without nucleation of new crystals (McPherson, 1998).  
Various techniques are available for protein crystallization: vapor diffusion, batch crystallization, 
and dialysis. In vapor diffusion, the initial reagent concentration in the droplet is less than that of 
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the well. The well solution pulls water from the droplet in a vapor phase thus increasing reagent 
concentration in the droplet leading to supersaturation. In contrast, the batch method attains 
supersaturation state instantaneously when the protein solution and precipitant are mixed. In 
dialysis, the supersaturated state is achieved by gradually increasing the precipitant concentration 
using a dialysis membrane (McPherson, 1999). 
 
 
Figure 1.9: Solubility phase diagram for crystallization from a solution. 
Obtaining highly diffracting crystals is the biggest bottleneck in protein crystallography. Protein 
crystals are difficult to grow, because protein molecules are spherical or ellipsoidal in shape, 
often with irregular surfaces, which do not easily pack without the formation of large holes 
between molecules. These holes are mainly filled with disordered solvent molecules. 
Nevertheless, it is possible to grow protein crystals by optimizing various parameters such as 
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protein purity and concentration, pH and ionic strength of buffer, temperature, precipitants, 
ligands and additives. The protein itself is perhaps the most important variable in crystallization; 
therefore, using mutants or homologues can sometimes dramatically improve crystallizability. It 
is common to screen many different conditions before the ideal set of conditions is found that 
will produce highly diffracting crystals. The quality of the crystal diffraction is critical to 
determining the final protein structure (McPherson, 1999).  
1.4.2 X­rays and Diffraction Theory 
 
X-rays are a form of electromagnetic radiation with wavelengths of about 0.1-100Å. The 
wavelength of x-rays is in the same order of magnitude as the bond lengths of atoms in protein 
molecules (0.5 -1.6 Å) (the reason why x-rays are used to locate atoms in crystals). X-rays can be 
produced by bombarding a metal target (copper or molybdenum) with high velocity electrons 
(produced by a heated filament and accelerated by an electric field). An accelerated electron then 
collides with and displaces an electron from a low-lying orbital in a target metal atom. An 
electron from a higher orbital fills the resulting vacancy, emitting its excess energy as an x-ray 
photon. There are three common sources of x-rays used in crystallography: x-ray tubes, rotating 
anode tubes, and particle storage rings. Of these, particle storage rings which produce 
synchrotron radiation in the x-ray region are the most powerful x-ray sources (Rhodes, 2000). 
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Figure 1.10: Constructive interference conditions: Ray 2 travels a longer distance than ray 1; the 
additional distance (CB + BD or 2BC) travelled by ray 2 can be given as 2dhklsinθ (path 
difference). If the path difference is equal to the integral number of wavelengths (nλ) then 
constructive interference occurs and a strong diffracted beam can be observed.  
 
Diffraction can be defined as scattering (change in the directions and intensities) of waves by 
objects whose size is approximately the same as the wavelength of the waves. W.L. Braggs  
(1913) envisioned diffraction of X-rays by crystals to be similar to reflections from sets of 
regularly spaced parallel planes in the crystal lattice. Scattering occurs in all directions, however 
measurable reflections (constructive interference) only occur when the path difference between a 
set of planes is equivalent to integral number of wavelengths i.e. nλ = 2dsinθ (Figure 1.10). 
Individual atoms in a molecule can diffract X-rays but are weak scatterers, resulting in weak 
diffraction that cannot be detected by the instrument. This problem can be solved by analyzing 
the diffraction pattern of a crystal rather than that of a molecule. Since crystals are composed of 
identical unit cells, the unit cells will diffract in unison to produce stronger measurable 
reflections. The diffraction spots measured represent an imaginary lattice (reciprocal lattice) that 
is inversely related to the real lattice. The reciprocal lattice has the same symmetry as the real 
lattice (Rupp, 2010; Rhodes, 2000).  
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It is important to measure intensity for each point in the reciprocal lattice during data collection. 
To do this, one must first predict which reciprocal lattice points are measurable, given the 
wavelength and orientation of the incident beam with respect to the crystal. A sphere (Ewald 
sphere or sphere of reflection) can be constructed such that any lattice point has to lie on its 
surface to be observed as a reflection i.e. to satisfy Braggs’ law.  The radius of the sphere of 
reflection is 1/λ, from the center of the crystal. During data collection, the crystal is rotated so 
that as many reciprocal lattice points as possible come into contact with the surface of the sphere 
of reflection. It is possible to move all lattice points within a radius of 2/λ (from the origin of the 
reciprocal lattice), to coincide with the surface of the sphere of reflection by rotating the crystal. 
A sphere with radius 2/λ is therefore called the limiting sphere corresponding to a resolution of 
λ/2 (Rhodes, 2000).  
1.4.3 Symmetry 
 
Crystals possess a high degree of internal order (symmetry). The subject of symmetry plays an 
essential part in all aspects of crystallography. There are seven crystallographic systems based on 
the relationships between a unit cell’s axes (a, b, c) and angles between them (α, β, γ). 
Combination of the 7 crystal systems with various types of lattice centering, results in 14 lattice 
types (Bravais lattices). Consequently, there are only fourteen unique ways to arrange identical 
points in a 3-D space. Points so arranged in the unit cell possess rotary and rotary-inversion 
operators, leading to 32 unique combinations of symmetry elements (point groups). When 
translational possibilities are included (screw axis and glide planes), 230 space groups are 
generated. However, proteins can only crystallize in 65 space groups, because they are chiral. If 
proteins were to crystallize in some space groups with symmetry operations like rotary-inversion 
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centres, they will change the asymmetry of their amino acids from L to D (Rupp, 2010; Rhodes, 
2000). 
The knowledge of crystal symmetry can aid data collection. Due to crystal symmetry, not all 
reflections in the sphere of reflections are unique; therefore, if the crystal symmetry is known 
only a fraction of the possible reflections needs to be measured. In addition to all the symmetry 
elements present in the real space, the reciprocal lattice has a center of inversion which further 
reduces the number of unique reflections by half (Friedel’s law). Crystal symmetry causes some 
specific reflections to disappear from the diffraction pattern (intensity of zero), due to destructive 
interference of those reflections. Information obtained from the missing reflections (systematic 
absences) can be used to derive the space group (Rupp, 2010; Rhodes, 2000).  
1.4.4 The Structure Factor Equation 
 
X-rays are scattered when they impinge on a crystal. The resulting diffraction pattern can be 
recorded by scintillation counters or area detectors. The relative positions and intensities of the 
reflections on a diffraction pattern contain information about the internal structure of the crystal. 
All atoms in the unit cell contribute to each reflection of the diffraction pattern as well to angles 
in between those reflections (because reflections result from constructive interference of all 
scattered rays that obey Bragg’s law), and each reflection represents a unique set of planes. 
Intensities have to be converted to structure factor amplitudes, before they can be used in the 
Fourier transformation to get the electron density. Intensities are proportional to the square of 
structure factor amplitudes.  
The structure factor (Fhkl) is a complex number which represents the total sum of amplitudes and 
phases from the entire unit cell contents.  It is obtained by adding up the scattering contribution 
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from each atom in the cell (fhkl) to the reflection hkl. The overall structure factor equation of a 
reflection is thus given by: 
Fhkl = Σ fneiα 
Where: i is the imaginary numberሺ√െ1ሻ,  fn is the scattering power of the atom and α is the phase 
angle of the scattered ray relative to the origin of the unit cell. Diffraction of x-rays by atoms is 
caused by electrons instead of the nucleus of an atom. The structure factor equation is therefore 
related to electron density and can be described by: 
Fhkl = ∫x∫y∫z ρ(x, y, z) eiα dxdydz 
or 
Fhkl = ∫vρ(x, y, z) eiαdv 
Where: ρ is the electron density, (x, y, z) are fractional coordinates of an atom in the unit cell and 
v is the unit-cell volume (Rhodes, 2000). 
1.4.5 The Phase Problem 
 
 X-rays are electromagnetic waves with phase angles, amplitudes and wavelengths. In order to 
solve a crystal structure based on reflections recorded on an x-ray film, one needs to know the 
phase angle, amplitude and wavelength of each reflection. The wavelength of the diffracted 
beam will be the same as the wavelength of the incident beam and the amplitude can be obtained 
by finding the square root of intensities measured by the detector. Finding the phase of the 
diffracted beam is a more difficult problem. Several methods have been developed over the years 
to overcome the phase problem in protein crystallography: anomalous dispersion, isomorphous 
replacement, and molecular replacement. For proteins which have homologous structures already 
solved such as those discussed in this thesis, molecular replacement is generally the method of 
choice because it does not require further experimental procedures. 
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1.4.6 Structure Solution by Molecular Replacement 
 
Molecular replacement uses a known protein structure (model structure) to estimate phases of 
another protein, if there is sufficient sequence identity (usually >40%). The success of this 
technique is based on the fact that proteins with high sequence identity often have similar three-
dimensional structures. To do molecular replacement, the known structure needs to be put in the 
correct position and orientation in the unit cell of the unknown protein. This process requires two 
steps: rotation and translation. First, the rotation function puts the known molecule (search 
model) in the same spatial orientation as the unknown molecule, and then the translation function 
superposes the correctly-oriented molecules. In both rotation and translation functions, the 
Patterson functions of the protein molecules are used. It is seen from section 1.2.4, that a Fourier 
transformation of the structure factors (amplitudes and phases) gives the electron density. What 
happens when a Fourier transformation of squared amplitudes only is performed? The result is a 
Patterson map, whose peaks represent vectors between atoms in the unit cell (Drenth, 2007).  
Atoms within the same molecule have short vectors which are close to the origin (intra-
molecular vectors). If there were no intermolecular vectors, the intra-molecular vectors of the 
known and unknown protein structures would be the same, except for a rotation difference. 
Therefore, intra-molecular vectors provide information about the rotational relationship between 
the known and the unknown molecular structures. There are software packages available that can 
calculate the intra-molecular vectors for a large number of different orientations using various 
mathematical procedures: Rossman and Blow procedures, Crowther’s fast rotation function, and 
maximum likelihood techniques. The orientation that has the best overlap between the known 
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and unknown models of intra-molecular vectors is taken as a possible correct orientation 
(Drenth, 2007).  
Once the correct rotational orientation has been obtained, the correct position of the known 
model within the unit cell of the unknown molecule is determined by translation. The Patterson 
functions of atoms from a different molecule within the same unit cell (symmetry-related 
molecules) are called intermolecular vectors. They are typically longer vectors which provide the 
translational relationship between the known and unknown protein structures. To locate the 
correct position, the known molecule is moved through the asymmetric unit of the unknown 
structure (usually by Fourier methods). The structure factors are then calculated and compared 
with the observed structure factors, by calculating an R-factor or the correlation coefficient, as a 
function of the molecular position (see Section 1.4.7). The position with the best correlation 
would be taken as the starting point for model building and refinement (starting phase angle to 
calculate electron density) (Drenth, 2007).  
1.4.7 Model Building, Refinement, and Validation 
 
Structure refinement is an iterative process which involves rebuilding (tweaking) of the model to 
find a closer agreement between the calculated and observed structure factors. First, the amino 
acid sequence is changed from that of the search model to the sequence of the protein of interest. 
The model is then manually adjusted to match the electron density map. The adjusted model is 
used to estimate new phase angles and recalculate the electron density. The process of manual 
adjustment and electron density calculation is then repeated several times, until the model is 
sufficiently refined, as judged by electron density and the crystallographic R-factor.  Once the 
model is sufficiently refined, water and other structural elements (e.g. cofactors, ligands) are 
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included in the model. The crystallographic R-factor is a measure of closeness between the 
model and the real structure. It is calculated by the equation below: 
 
                                                          ܴ    ൌ  ∑ห׀F୭׀ି׀Fୡ׀ห
∑|F୭|
 X 100
ܨ݋| ܨܿ|
|ܨ݋
 
Where |  and |  are observed and calculated structure factors respectively. There are several 
software packages available for crystallographic refinement. Examples include: CNS (Brunger, 
2007), REFMAC (Murshudov et al, 1997) and PHENIX (Adams et al, 2010). These programs 
use one of two methods for refinement: maximum likelihood refinement or least-squares 
refinement. All refinement programs use empirical restraints or constraints (bond lengths, bond 
angles, torsion angles, and van der Waals contacts) to arrive at a reasonable structure when 
refinement is complete.  
A well refined high resolution structure (< 2 Å) structure would have an R-factor of less than 
20% whereas a random acentric structure would have an R-factor of 59%. However, it has been 
found that some incorrectly-built protein structural models can also have R-factors of less than 
20% due to model bias. A cross-validation index (R-free) is used to detect this problem. Before 
the start of refinement, unique reflections are divided into two groups: a “test set” and a 
“working set”. The test set consists of 5~10 % of the observed reflections and the working set 
consists of all the remaining reflections. Refinement is then carried out with the working set 
only, and the test set is used for cross-validation according to the equation above; except that the 
structure factors, |, of the test set reflections are used instead of the working set reflections 
(Drenth, 2007). 
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1.5 MODEL SYSTEMS 
1.5.1 D. radiodurans 
 
Deinococcus radiodurans (D. radiodurans) is a Gram positive bacterium capable of 
withstanding exposure to extreme γ-ray and ultraviolet radiation, oxidants, and desiccation. D. 
radiodurans can survive exposure to γ-rays (more than 4000 Gy). In contrast, exposure to less 
than 200 Gy is lethal to most other bacteria (Cox & Battista, 2005; Daly, 2009). Because of its 
ability to withstand cellular toxicity caused by oxidants and ionizing radiation, transgenic D. 
radiodurans may be useful in bioremediation of waste sites contaminated with radionuclide 
contaminants (Brim et al, 2006). As a result D. radiodurans has been the subject of intense 
research aimed at understanding the basis of its ability to survive exposure to extreme conditions, 
and how it can be used in bioremediation of toxic waste sites (Brim et al, 2006; Cox & Battista, 
2005; Dennis et al, 2006). D. radiodurans’ unusual capabilities have been attributed to a high 
number of genome copies (Daly et al, 2004), ring-like nucleoid organization (Levin-Zaidman et 
al, 2003), high manganese content (Daly et al, 2004), and a higher ability to scavenge ROS (Tian 
et al, 2007). However, the mechanism responsible for its extremophilic nature is not clearly 
understood (Makarova et al, 2001).  
Although ionizing radiation, desiccation and the presence of oxidants can cause different types of 
damage to the genome, DNA double stranded breaks (DSB) are considered to be the most lethal 
(Daly, 2009). As a result, efforts to understand the mechanism behind D. radiodurans’ ability to 
tolerate extreme conditions have been focused on understanding its ability to prevent or repair 
DSB (Daly, 2009). Indeed, some experimental evidence suggests that efficient DNA repair is 
solely responsible for D. radiodurans’ ability to withstand ionizing radiation. D. radiodurans’ 
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sustains the same amount of DNA damage at high radiation doses as other bacteria, but unlike 
other bacteria its damage is mended within hours (Daly, 2009; Makarova et al, 2001). However, 
some recent evidence suggests that it is likely that prevention of DNA damage (ROS scavenging) 
supplements DNA repair to make D. radiodurans’ ionizing radiation tolerant. It is worth noting 
that only about 20% of radiation-induced damage to the genome is due to the direct effect of 
irradiation (the rest is due to radiation-induced ROS), and that cellular extracts of D. radiodurans 
are more effective in scavenging ROS than E. coli extracts when subjected to oxidative stress 
(Tian et al, 2007).  Moreover, D. radiodurans has higher basal levels of some antioxidant 
enzymatic systems (catalase and superoxide dismutase) and disruption of superoxide dismutase 
(sodA) and catalase (katA) genes results in increased sensitivity of D. radiodurans to ionizing 
radiation. In addition, D. radiodurans catalase is more resistant to inhibition by substrate H2O2, 
than bovine or Aspergillus niger catalase (Kobayashi et al, 2006). Taken together these 
experimental results suggest a significant contribution of antioxidant systems to D. radiodurans 
ability to withstand extreme ionizing radiation. While the contribution of some antioxidant 
enzymatic systems to the extremophilic nature of D. radiodurans has been extensively studied, 
the role of the thioredoxin system has not been investigated (Tian et al, 2007). D. radiodurans 
has two thioredoxin genes and a single thioredoxin reductase gene which form part of its defence 
against oxidative damage. Therefore, as part of the enzymatic systems that protect D. 
radiodurans against ROS damage, characterization of the thioredoxin system may contribute to 
understanding the extremophilic nature of D. radiodurans.  
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1.5.2 H. pylori 
 
Helicobacter pylori (H. pylori) is a microaerophilic, gram-negative bacterium capable of 
colonizing the mucosal lining of the stomach. This gastric colonization has been associated with 
peptic ulcer, gastritis, and gastric cancer (Baker et al, 2001a). H. pylori avoids the highly acidic 
environment of the stomach by living within the thick mucus lining protecting the stomach from 
gastric juice. Its ability to survive in the stomach is enhanced by its motility (Eaton et al, 1992), 
activity of its urease enzyme (Marshall et al, 1990), and its gastric adherence properties (Zhang 
et al, 2002). It contains flagella which helps it to move rapidly into the mucosal lining of the 
stomach in order to avoid long exposure to gastric juices (Eaton et al, 1992). In addition to rapid 
movement, H. pylori generates ammonia (base) through the action of its urease enzyme to 
protect itself from stomach acids (Marshall et al, 1990). Urease catalyzes the hydrolysis of urea 
into ammonia and carbon dioxide. Ammonia is then used to neutralize the stomach acid. 
Although the majority of the colonizing bacteria remain in the mucosal lining of the stomach, 
some adhere to the gastric epithelial cells. This adherence is facilitated by its adhesins and other 
virulence factors (Zhang et al, 2002). 
Upon colonization, H. pylori secretes immunogenic products that recruit macrophages to the site 
of infection producing a large amount of ROS. Long term exposure to ROS damages gastric 
tissues, and is thought to be a causative factor in human gastric cancer (Baker et al, 2001a; 
Correa, 1995; Davies et al, 1994). To protect itself from ROS damage, H. pylori has several 
protective enzymatic systems including catalase, superoxide dismutase, and thioredoxin. 
However, it lacks the glutathione system which is found in other bacteria (Baker et al, 2001a). 
Like D. radiodurans, H. pylori also contains two Trxs (Trx1 and Trx2) and a single TrxR as part 
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of its Trx system. Both H. pylori Trx1 and Trx2 show high sequence identity (51 and 41 % 
respectively) to E .coli Trx (Baker et al, 2001a; Windle et al, 2000). However, Trx2 shows an 
unusual active site motif (CPDC), instead of the highly conserved active site motif (CGPC) 
found in other Trxs (Windle et al, 2000).  
The H. pylori Trx system is somewhat unique among bacterial Trxs. H. pylori secretes Trx when 
subjected to a variety of stresses; the only other known example of secreted Trx is human Trx. It 
has therefore been postulated that the Trx system plays a role (reduction of disulfides) in 
colonization of the disulfide-rich mucosal lining of the stomach; a property that may be essential 
for its viability (Windle et al, 2000). Because of its role in ROS scavenging and possibly in 
infiltration of the gastric mucin layer, the H. pylori Trx system has been mentioned as a potential 
new antibacterial drug target (Gustafsson et al, 2007; Windle et al, 2000). Therefore 
characterization of the H. pylori Trx system may provide insight on how protein-protein 
interactions of the H. pylori Trx system could be disrupted. 
1.6 INDUSTRIAL AND PHARMACEUTICAL APPLICATIONS OF THE 
THIOREDOXIN SYSTEM 
 
The Trx system has the potential for many pharmaceutical and industrial applications. 
Exogenous addition of all Trx system components improved the quality of wheat flour by 
reducing the disulfide bonds of storage proteins (e.g. glutelins and prolamins) making the wheat 
flour more digestible (Joudrier et al, 2005). Transgenic barley overexpressing Trx was found to 
have shorter germination periods because of the enhanced activity of starch de-branching 
enzyme (Gautier et al, 1998; Joudrier et al, 2005). Reduction of disulfides of some food 
allergens, e.g. from wheat (gladians and glutenins) and milk (β-lactoglobulin) by Trx attenuated 
their allergenicity (Buchanan et al, 1997; Joudrier et al, 2005). Many venom toxins from snakes, 
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bees, and scorpions are inactivated by reduction, since their native form contains disulfides 
(Joudrier et al, 2005). Success of these applications will depend on efficient protein-protein 
interactions of various Trx system partners. Therefore, the ability to fine-tune the binding 
specificity of TrxR-Trx and/or Trx-target protein will enhance many of these potential 
applications of the Trx system. A systematic study of the TrxR-Trx interface can provide new 
insight on the basis of the binding specificity and may simplify the process of redesigning the 
Trx system with new specificities and/ or improved efficiencies. 
1.7 AIMS AND OBJECTIVES 
 
This work was undertaken with three goals.  
1. To determine the affinity of D. radiodurans TrxR for E. coli and D. radiodurans Trxs 
2. To determine the redox activity of  the D. radiodurans Trx system 
3. To determine the basis of species-specificity of TrxR-Trx interactions 
Previous studies have shown that TrxRs have a higher affinity for cognate Trxs over Trxs from 
other species (Baker et al, 2001a; Gustafsson et al, 2007). The first objective was to determine if 
DR TrxR showed higher affinity for its cognate Trx over Trxs from another species (E. coli), 
using spectrophotometric and biophysical approaches.  
It has also been previously shown that cell extracts of D. radiodurans are more efficient in 
scavenging ROS than those from E. coli, and that the higher ROS scavenging capability of D. 
radiodurans contributes to its extremophilic nature (Daly, 2009; Mattimore & Battista, 1996). 
The second objective was to determine the redox activity of the D. radiodurans Trx system using 
spectrophotometric assays, and to compare it with that of E. coli.  
Previous studies have shown that TrxRs have a higher affinity for cognate Trxs than Trxs from 
other species. The differences in specificity have been attributed to differences in the size of loop 
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regions of the FAD-binding domains (in eukaryotic LMW TrxR) (Zhang et al, 2009) and 
differences in the charge and shape of thioredoxin-binding surfaces (in bacterial LMW TrxR) 
(Gustafsson et al, 2007; Obiero et al, 2010), however no systematic study has been carried out to 
determine the basis of specificity. The third objective was to determine the basis of species-
specificity of TrxR-Trx interactions, and the contribution of specific amino acid residues to 
TrxR-Trx interface stability and species specificity, using x-ray crystallographic, computational, 
and biochemical approaches. 
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CHAPTER TWO: MATERIALS AND METHODS 
2.1 PROTEIN OVEREXPRESSION 
 
Conditions for overexpression and induction for various proteins are shown on Table 2.1 below. 
After overexpression and induction the cells were harvested by centrifugation (20 min, 8000 g, 
277 K) and the pellets stored at -80 ºC. 
 
Plasmid Host  cell 
strain 
Media Antibiotics 
    (µg/L) 
Induction 
OD600 
[IPTG] 
 
µM 
Harvesting 
time after  
induction 
Induction 
temperature
pPROK1/Trx1 BL21Gold LB Ampicillin 
    (100) 
   0.9 0.4 16 hours 37ºC 
pPROK1/Trx2 BL21Gold LB Ampicillin 
    (100) 
   0.6 0.4 3 hours 37ºC 
pPROK1/TrxR Rossetta2 LB Ampicillin 
    (100) 
   0.9 0.4 16 hours 37ºC 
 
Table 2.1A: Overexpression and induction conditions for H. pylori proteins 
 
Plasmid Host  cell 
strain 
Media Antibiotics 
    (µg/L) 
Induction 
OD600 
[IPTG] 
 
µM 
Harvesting 
time after  
induction 
Induction 
temperature 
pHISTEV/Trx1 Rossetta2 LB Kanamycin 
    (50) 
   0.6    0.25 4 hours 30ºC 
pHISTEV/TrxR Rossetta2 LB Kanamycin 
    (50) 
   0.6    0.4 16 hours 30ºC 
 
Table 2.1B: Overexpression and induction conditions for D. radiodurans proteins 
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Plasmid Host  cell 
strain 
Media Antibiotics 
    (µg/L) 
Induction 
OD600 
[IPTG] 
 
µM 
Harvesting 
time after  
induction 
Induction 
temperature 
pHISTEV/Trx1 Rossetta2 LB Kanamycin 
    (50) 
   0.6    0.4 4 hours 37ºC 
pHISTEV/TrxR Rossetta2 LB Ampicilin 
    (100) 
   0.6    0.4 16 hours 30ºC 
 
Table 2.1C: Overexpression and induction conditions for E. coli proteins 
2.2 PROTEIN PURIFICATION 
2.2.1 Purification of HP Trx1 
 
Helicobacter pylori thioredoxin-1 (HP Trx1) was purified as previously described (Baker et al, 
2001a; Pervin, 2006). Briefly the cells were induced and harvested by centrifugation (Table 
2.1A). The crude cell extracts were suspended in 25 mM potassium phosphate buffer (pH 7.0) 
containing 1 mM ethylenediamine tetra-acetic acid (EDTA) and stirred at 4°C for 30 min in the 
presence of DNase and lysozyme (2.5% w/v). After sonication and centrifugation, the 
supernatant was subjected to heat denaturation at 70ºC for 4 min to remove contaminating 
proteins. Denatured proteins were removed via centrifugation and the supernatant was dialyzed 
overnight in three changes of 5 mM potassium phosphate buffer (pH 7.0).  The dialyzed protein 
was filtered using an acrodisc syringe filter and loaded to a diethylaminoethyl-cellulose (DEAE-
cellulose) column which was pre-equilibrated with 10 mM potassium phosphate buffer (pH 7.0). 
A linear gradient of 10 to 100 mM potassium phosphate was applied to elute the protein of 
interest. The resulting fractions were analyzed on a sodium dodecyl sulfate- polyacrylamide gel 
electrophoresis (SDS-PAGE) gel and then concentrated to 5 mL before loading onto a gel 
filtration column. Twenty five mM potassium phosphate buffer with 1 mM EDTA was used as 
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equilibration buffer and the protein was eluted with 200 mM NaCl. The purity of the protein was 
assessed by SDS-PAGE and NaCl was removed by dialysis against 25 mM potassium phosphate 
buffer with 1 mM EDTA. The pure protein was concentrated to an appropriate volume, before 
measuring the concentration using Bradford assay (1976) and storage as aliquots at -80°C. 
2.2.2 Purification of HP Trx2 
 
After centrifugation Helicobacter pylori thioredoxin-2 (HP Trx2) crude extracts were treated as 
described for HP Trx1, except for the following modifications. Contaminating proteins were 
removed by a 30% ammonium sulfate precipitation and a 4 minute 50ºC heat denaturation. The 
resulting supernatant was dialyzed against 5 mM potassium phosphate buffer pH 7.0. The 
dialyzed protein was then applied to the anion exchange (DEAE-cellulose, Whatman) column 
pre-equilibrated with 5 mM potassium phosphate buffer, pH 7.0 and the flow-through fraction 
was collected. The flow-through fraction was then concentrated and loaded onto a cation 
exchange column (carboxymethyl cellulose, Whatman) pre-equilibrated with 5 mM potassium 
phosphate buffer, pH 7.0. The protein was eluted with a linear gradient of 5 to 60 mM potassium 
phosphate, pH 7.0. SDS-PAGE was again used to assess purity and the protein was stored at -
80°C after measuring its concentration by the Bradford assay.  
2.2.3Purification of HP TrxR 
 
Purification of Helicobacter pylori thioredoxin reductase (HP TrxR) has also been previously 
described (Baker et al, 2001a; Pervin, 2006).  After induction, the cells were harvested by 
centrifugation. The cell pellets were then resuspended in sonication buffer (50 mM potassium 
phosphate buffer pH 7.0, 1 mM 4-(2- Aminoethyl) benzenesulfonyl fluoride (AEBSF), 20 mg 
ml-1 DNase and 20 mg ml-1 lysozyme),  and  incubated at 4°C for 30 min. After sonication and 
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centrifugation, the supernatant was subjected to heat denaturation 4 min at 50ºC, and 20% 
ammonium sulfate treatment to remove contaminating proteins. An 80% ammonium sulfate 
treatment was then applied to the resulting supernatant to precipitate TrxR. After the 80% 
ammonium sulfate treatment, the protein was resuspended and dialyzed (10 mM potassium 
phosphate buffer pH 7.0) before loading onto the DEAE-cellulose column and elution with a 
linear gradient with NaCl (20 mM potassium phosphate buffer pH 7.0 to 500mM NaCl, 20 mM 
potassium phosphate buffer pH 7.0). Fractions containing TrxR, as assessed by the ratio of 
A280/A450 were pooled, concentrated and loaded onto an Affinity Gel Blue column (BIORAD) 
preequilibrated with a 25mM potassium phosphate buffer, pH 7.0. The protein was then eluted 
with a linear gradient of potassium phosphate buffer (25 mM potassium phosphate buffer pH 7.0 
to 0.3 M NaCl in 600 mM potassium phosphate pH, 7.0). The purity of the final purified TrxR 
fractions was assessed by SDS-PAGE. Those fractions that were judged to be of high purity were 
pooled and dialyzed overnight against 50 mM Tris–HCl pH 8.0 buffer. 
2.2.4 Purification of DR TrxR and Mutants 
 
Deinococcus radiodurans thioredoxin reductase (DR TrxR) was purified as previously described 
(Obiero et al, 2006). The frozen DR TrxR cell pellets were thawed and resuspended in sonication 
buffer (50 mM Tris–HCl, pH 8.0, 1 mM AEBSF, 20 mg ml-1 DNase and 20 mg ml-1 lysozyme). 
The thawed cells were mechanically disrupted by sonication and cell debris was removed by 
centrifugation. The resulting supernatant was loaded onto a POROS MC50 metal-chelation 
column (Applied Biosystems, USA) pre-equilibrated with a buffer containing 5 mM imidazole, 
0.5 M NaCl, 50 mM Tris–HCl, pH 8.0. The column was washed with a 60 mM imidazole, 0.5 M 
NaCl, 50 mM Tris–HCl pH 8.0 buffer to remove non-specific binding and the protein eluted with 
a 0–1 M imidazole gradient. Fractions (10 ml) were collected and the purity of the protein was 
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checked on Coomassie-stained SDS–PAGE. Those fractions showing a high level of purity were 
pooled and dialyzed against crystallization buffer (50 mM Tris–HCl, pH 8.0). All DR TrxR 
mutants were purified as described for the wild type protein. 
2.2.5 Purification of DR Trx1 
 
DR Trx1 was purified as previously described (Obiero et al, 2010). The frozen DR Trx1 cell 
pellets were thawed on ice and resuspended in 5 mM EDTA, 50 mM Tris-HCl at pH 8.0, 0.5% 
Triton X-100, 1 mM AEBSF, 20 mg ml-1 DNase, and 20 mg ml-1 lysozyme. The thawed cells 
were mechanically disrupted by sonication and centrifuged (20 min, 8,000 x g, 4°C). The protein 
was found in inclusion bodies by SDS-PAGE analysis of the resulting pellet and supernatant. It 
was then solubilized from the pellet by resuspending the pellet in 5 mM EDTA, 50 mM Tris-HCl 
at pH 8.0 and 0.5% DOC, followed by sonication and centrifugation (26,500 x g). The resulting 
supernatant and pellet were separated by decanting. The solubilization procedure was repeated 
for the pellet. The two supernatants were pooled and loaded onto a POROS MC50 metal 
chelation column (Applied Biosystems, USA) preequilibrated with a buffer containing 1 mM 
imidazole, 0.5 M NaCl, and 50 mM Tris-HCl at pH 8.0. The column was washed with the same 
buffer to remove nonspecific binding, and the protein was eluted with a 0 to 0.5 M imidazole 
gradient. Peak fractions (5 ml) were collected, and the purity of the protein was checked using 
Coomassie blue-stained SDS-PAGE. Those fractions showing high levels of purity were pooled 
and concentrated. The concentrated protein was then dialyzed against 50 mM potassium 
phosphate buffer at pH 8. 
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2.2.6 Purification of EC TrxR 
 
EC TrxR was purified using an HQ 20 anion-exchange column (Applied Biosystems, USA) and 
a Cibacron Blue column. The HQ 20 anion-exchange column was preequilibrated with 25 mM 
potassium phosphate buffer, pH 8.0. The protein was eluted with a linear gradient of 0 to 500 
mM NaCl. The eluted fractions were analyzed by SDS-PAGE. Then the fractions that contained 
the EC TrxR were applied to an Affinity Gel Blue column preequilibrated with a 25 mM 
potassium phosphate buffer, pH 7.0. The protein was eluted with a linear gradient of 25 mM 
potassium phosphate buffer to 0.3 M NaCl in 600 mM potassium phosphate pH 7.0. Peak 
fractions (5 ml) were collected, and the purity of the protein was checked by SDS-PAGE 
analysis. Those fractions showing high levels of purity were pooled and concentrated. The 
concentrated protein was then dialyzed against 50 mM potassium phosphate buffer at pH 8.0. 
2.2.7 Purification of EC Trx 
 
EC Trx was purified as described for DR TrxR (Section 2.2.4) 
2.3 DETERMINATION OF PROTEIN PURITY 
 
The purity of various protein samples was checked using SDS-PAGE. In this technique, 
separation based on molecular weights is obtained by the sieving properties of different 
percentage gels, because of the uniform shape and charge of the protein conferred by SDS and 
reducing agents. 10% and 15% gels were used to assess the purity level of proteins. These gels 
were prepared according to standard recipes (Sambrook & Russell, 2001).  
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2.4 ESTIMATION OF PROTEIN CONCENTRATION 
 
The concentration of the various proteins was estimated using the Bradford assay (Bradford, 
1976). First a standard calibration curve was constructed using known concentrations of bovine 
serum albumin (BSA). The standard samples and unknown protein samples were prepared 
according to Table 2.3. The Bradford reagent and BSA were purchased from Sigma-Aldrich 
Canada Ltd. The samples and standards were incubated for 20-30 min at room temperature 
before measuring the absorbance at 595 nm by UV/VIS spectrophotometry.  
 
Bradford Standard 
     (µg/mL) 
0.1 µg/mL 
   BSA (µL) 
    dH2O  
      (µL) 
 Bradford Reagent 
            (µL) 
                0           0       500              500 
                1          10       490              500 
                2          20       480              500 
                3          30       470              500 
                5          50       450              500 
               10        100       400              500 
Unknown sample                   
         1 or 2 µL           0  499/498              500 
        
Table 2.2: Preparation of Bradford standards and unknown sample 
 
 
 
 
43 
 
  
 
2.5 PREPARATION OF MUTANTS 
 
All site-directed mutagenesis experiments were performed using the QuickChange site-directed 
mutagenesis kit from Stratagene (USA). With the exception of the extension time (which was 
increased from 1 min/kilobase to 2 min/kilobase), all the PCR parameters were maintained 
according to the instructions on the kit. The polymerase chain reaction (PCR) reaction mixture 
contained: 50 ng DNA template, 1X PCR reaction buffer, 125 ng forward primer, 125 ng reverse 
primer and 2.5 units of Pfu Turbo DNA polymerase. The primers used were designed with help 
of a program (MutPrimer) recommended by the kit. The list of primers is shown in Table 2.3. 
Following temperature cyling, the reaction was cooled to 25ºC and digested with 10 units of 
DpnI at 37 ºC for 1 hour, to cleave parental methylated DNA. Fifty µL of competent NovaBlue 
cells were then transformed with 1 µL of the DpnI-digested reaction mixture and added to 250 
µL LB media at room temperature. The cells were then grown at 37ºC for 1 hour with shaking at 
250 rpm, and the whole transformation mixture was plated on LB agar plates (with appropriate 
antibiotic). The plates were then incubated overnight at 37ºC. A few colonies from each plate 
were used to inoculate 4 mL of LB media and incubated at 37ºC overnight with shaking at 250 
rpm. After the overnight incubation, the plasmid was isolated using the QIAprep spin miniprep 
kit and the presence of the desired mutation was confirmed by DNA sequencing (Figure 2.1). 
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1     ATGAGTGACATCCTGACCTGTACCCACTGCCAGGCCAAAAACCGCGTCGGTGCTGTGCCC 
      |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
147   ATGAGTGACATCCTGACCTGTACCCACTGCCAGGCCAAAAACCGCGTCGGTGCTGTGCCC 
 
61    GCCGGACAGGTGCCGAGCTGCGCCCGCTGCGGCGCCGCGCTGCCCTGGCTGCACGACGGC 
      |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
207   GCCGGACAGGTGCCGAGCTGCGCCCGCTGCGGCGCCGCGCTGCCCTGGCTGCACGACGGC 
 
121   ACCGACGCGACCTTCGAGCAGGACCTTCAGACAAGCGTGCCGGTGCTGGTGGACTTCTGG 
      |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
267   ACCGACGCGACCTTCGAGCAGGACCTTCAGACAAGCGTGCCGGTGCTGGTGGACTTCTGG 
 
181   GCGCCGTGGTGCGGCCCCTGCCGCGTGATGGGGCCGGTTCTCGAAGACCTCGCCCGCGAC 
      |||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
327   GCGCCGTGGTCCGGCCCCTGCCGCGTGATGGGGCCGGTTCTCGAAGACCTCGCCCGCGAC 
 
241   CTGCCCGGCAAGGTGCGGGTGGTGAAGGTCAACGTGGACGAGAACCCGCGCACCGCCGCC 
      |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
387   CTGCCCGGCAAGGTGCGGGTGGTGAAGGTCAACGTGGACGAGAACCCGCGCACCGCCGCC 
 
301   CGTTTCGAGGTCCGCAGCATTCCCACGCTGCTGATGTTCAAGGACGGGGAAGAGGTGGAC 
      |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
447   CGTTTCGAGGTCCGCAGCATTCCCACGCTGCTGATGTTCAAGGACGGGGAAGAGGTGGAC 
 
Figure 2.1: Confirmation of mutagenesis by DNA sequence alignment. The mutant sequence 
(C64S DR Trx1) is shown as the bottom line and parental sequence is shown as the top line. The 
figure was generated by DNAMAN (Lynnon Corp., USA). 
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Mutant Protein Primer 
C133S H. pylori TrxR Forward primer: 
5’ GGTAAAGGCGTTAGCACTAGCGCGACATGC 3’ 
Reverse primer: 
5’ GCATGTCGCGCTAGTGCTAACGCCTTTACC 3’ 
C30S H. pylori Trx1 Forward primer: 
5’ GGCGCCATGGAGTGGGCCTTGTAAGATG 3’ 
Reverse Primer: 
5’ CATCTTACAAGGCCCACTCCATGGCGCC 3’ 
C142S D. radiodurans TrxR Forward primer: 
5’ CAAAGGCGTGAGCACCAGCGCCACCTGC 3’ 
Reverse primer: 
5’ GCAGGTGGCGCTGGTGCTCACGCCTTTG 3’ 
C145S D. radiodurans TrxR Forward primer: 
5’ GCACCTGCGCCACCAGCGACGGCTTTT 3’ 
Reverse primer: 
5’ AAAAGCCGTCGCTGGTGGCGCAGGTGC 3’ 
K137R D. radiodurans TrxR Forward 
5’ GACAACTTCTGGGGCAGAGGCGTGAGC 3’ 
Reverse 
5’ GCTCACGCCTCTGCCCCAGAAGTTGTC 3’ 
K137A D. radiodurans TrxR Forward 
5’ ACAACTTCTGGGGCGCAGGCGTGAGCACC 3’ 
Reverse 
5’ GGTGCTCACGCCTGCGCCCCAGAAGTTGT 3’ 
F148A D. radiodurans TrxR Forward 
5’ CCACCTGCGACGGCGCTTTCTATAAGGGCAAGA 3’ 
Reverse 
5’ TCTTGCCCTTATAGAAAGCGCCGTCGCAGGTGG 3’ 
F149A D. radiodurans TrxR Forward 
5’ CGACGGCTTTGCCTATAAGGGCAAGAAAGTCGTGG 3’ 
Reverse 
5’ CCACGACTTTCTTGCCCTTATAGGCAAAGCCGTCG 3’ 
M84A D. radiodurans TrxR Forward 
5’ GCCAAAGTGGAGGCGGACGAGGTGCAGGGC 3’ 
Reverse 
5’ GCCCTGCACCTCGTCCGCCTCCACTTTGGC 3’ 
M84F D. radiodurans TrxR Forward 
5’ CCAAAGTGGAGTTCGACGAGGTGCAGGGCGTGC 3’ 
Reverse 
5’ GCACGCCCTGCACCTCGTCGAACTCCACTTTGG 3’ 
C64S D. radiodurans Trx1 Forward 
5’ CTGGGCGCCGTGGTCCGGCCCCTGC 3’ 
Reverse 
5’ GCAGGGGCCGGACCACGGCGCCCAG 3’ 
C67S D. radiodurans Trx1 Forward 
5’ CGTGGTGCGGCCCCTCCCGCGTGATGG 3’ 
Reverse 
5’ CCATCACGCGGGAGGGGCCGCACCACG 3’ 
 
Table 2.3: List of primers used for site-directed mutagenesis 
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Number of repeats Step Temperature (ºC) Time 
1 1 95 (denaturation) 30 seconds 
 
16 
2 95 (denaturation) 30 seconds 
3 55 (annealing) 1 minute 
4 72 (extension) 14 minutes (2 min/kb) 
1 5 25 (cooling) 2 minutes 
 
Table 2.4: PCR conditions for mutagenesis 
2.6 ACTIVITY ASSAYS 
2.6.1 Insulin Reduction Assay 
 
The insulin reduction assay monitors the consumption of NADPH by measuring the decrease in 
absorbance at 340 nm. The assay mixture (1 mL) contained 100 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer (pH 7.4), 2 mM EDTA, 30 µM bovine insulin 
(Sigma), 0.1 mM NADPH (Calbiochem), 0.1 µM various TrxRs and various Trxs (0.5 µM -125 
µM). All the measurements were carried out at room temperature using a Cary 50 
spectrophotometer (Varian). The reaction was initiated by adding Trx and the resulting change in 
absorbance was recorded. The data were fit to a straight line over a ~1 min range to calculate the 
change in absorbance/min. Initial velocities were calculated as µM of NADPH oxidized/min in 
accordance with the relationship Vo = ∆A340/0.0062 (Holmgren & Morgan, 1976). Kinetic 
parameters were obtained from the plot of initial velocity versus substrate concentration, i.e. the 
Michaelis-Menten plot. 
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2.6.2 DTNB Reduction Assay 
 
In this assay 5, 5’- Dithio-bis (2-nitrobenzoic acid) (DTNB) acts as the final recipient of reducing 
equivalents. The reaction mixture contained 20 mM HEPES  (pH  7.4), 2 mM EDTA, 0.24 mM 
NADPH, 0.1 µM TrxR (various), 1.26 mM DTNB and (0.1-20 µM) Trx (various) in a final 
volume of 1 mL. The reaction was initiated by adding DTNB and monitored by the increase in 
absorbance at 412 nm in a Cary 50 spectrophotometer (Varian). Initial velocities were calculated 
as µM of DTNB reduced/min in accordance with the relationship Vo = ∆A412/0.0136 (Luthman 
& Holmgren, 1982; Navarro et al, 1991). Kinetic parameters were also obtained from the plot of 
initial velocity versus substrate concentration. 
2.7 FLUORESCENCE MEASUREMENTS 
 
The fluorescence measurements were performed using a Photon Technology International (PTI) 
Fluorescence Master Systems fluorimeter and the fluorescence spectra recorded with Felix32 
software. Purified samples of wild type EC TrxR and EC TrxR C145S mutant were dialyzed in 
50 mM K2HP04 pH 7.5 and then concentrated to 4 mg/mL before doing the fluorescence 
measurements. The excitation wavelength was set at 455 nm and the emission wavelength was 
set at 515 nm. Instrumental parameters were: configuration was set to digital-double-double for 
both excitation and emission scans; slit width of 2.00 nm; hardware integration time of 3 
seconds; data collection time of 1 second; average set to 1; number of points for one average was 
set to 5; lamp power supply was set at 70 watts; step size was set to 1 nm; and voltage of the 
photon-multiplier was set at 1101V. Data is collected as a voltage signal which is proportional to 
fluorescence intensity (number of photon/second) with arbitrary units. 
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2.8 THIOREDOXIN REDUCTASE­THIOREDOXIN COMPLEX FORMATION 
 
Aliquots of a Trx active site cysteine mutant (HP Trx C28S) were treated with dithiothreitol 
(DTT) by incubation with a ~20 fold excess of fresh DTT at room temperature for 30 min to 
assure that the remaining thiol was fully reduced. The reaction mixture was concentrated with 
Amicon filtration units to a volume of about 3 mL and mixed with fresh buffer to a final volume 
of about 15 mL. The filtration and concentration process was repeated several times (~5 times), 
until there was no DTT detected in the filtrate (DTT can be detected by reacting the filtrate with 
a DTNB solution and observing if there is any increase of absorbance at 412 nm). The 
concentration of the final sample was determined by the Bradford assay. The desalted Trx 
mutants were then reacted with an ~80-fold excess of DTNB and monitored at 412 nm for the 
completion of the reaction. DTNB was also removed by several rounds of filtration and 
concentration. DTNB removal was determined to be complete when there was no more 
characteristic yellow color in the filtrate. For the D. radiodurans active site cysteine Trx mutants, 
dialysis was used for the desalting process, because the protein easily precipitated upon 
concentration. A sample of the desalted mixed disulfide Trx-TNB was used directly in the 
reaction with TrxR active site cysteine mutant (DR TrxR C142S mutant). The TrxR mutant was 
also pre-treated with DTT (to make sure the remaining active site thiol was also in the reduced 
state) and desalted in a similar manner to the Trx mutant, before it was reacted with Trx-TNB. 
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2.9 CRYSTALLIZATION AND CRYSTAL HARVESTING 
2.9.1 HP TrxR 
 
HP TrxR was concentrated to 10 mg mL-1 (in 20mM Tris buffer pH 8.0) and used for broad 
screen crystallization trials with sitting drop vapour diffusion. Two conditions (2.2 M ammonium 
sulfate, 0.2 M lithium nitrate/2.2 M ammonium sulfate, 0.2 M ammonium nitrate) from the 
ammonium sulfate broad screen yielded crystals. Grid screening and additive screening were 
performed based on these results to find the optimal crystal growth conditions at 20.0 0C. The 
crystals also grew reprodubibly at 4.0 0C. 
 
2.9.2 DR TrxR 
 
The purified DR TrxR was also concentrated to 10 mg mL-1 (in 20mM Tris buffer pH 8.0) and 
used for crystallization trials at 20.0 0C. Initial screening was performed by the sitting-drop 
vapour-diffusion method using broad screens from Qiagen. A 4 mL drop consisting of 2 mL well 
buffer and 2 mL protein solution was equilibrated against 100 mL reservoir buffer.  
 
2.10 DATA COLLECTION AND PROCESSING 
 
HP TrxR crystals were soaked in cryoprotectant solution for a few seconds prior to flash cooling 
in a nitrogen cold stream. The cryoprotectant solution contained 2% glycerol, 3.5 M ammonium 
sulfate and 0.2 M ammonium nitrate. X-ray diffraction data were collected at 100 K on beamline 
08-1D.1 using Mar225CCD detector at the Canadian Light Source (Table 3.2). The crystal-to-
detector distance was set to 180 mm with an oscillation range of 0.5º and a total of 360 images (1 
s exposure time for each image) were collected that covered a total oscillation range of 180º. The 
images were integrated and scaled using XDS/XSCALE (Kabsch, 1993). 
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DR TrxR diffraction data were collected using an ADSC Q315 detector on beamline 14-BM-C at 
BioCARS, Advanced Photon Source (APS), Chicago, IL, USA. The crystal-to-detector distance 
was maintained at 275 mm with an oscillation range per image of 0.5º, covering a total 
oscillation range of 90º. The resulting intensity data were indexed and integrated using 
MOSFLM (Leslie, 1992), scaled and merged using SCALA (Collaborative Computational 
Project, Number 4, 1994) and converted to structure factors using TRUNCATE (Collaborative 
Computational Project, Number 4, 1994).  
2.11 HOMOLOGY MODELING 
 
Models of DR Trx1 and the FR conformation of DR TrxR were generated by MODELLER 9v1 
(with default parameters). Coordinates of the EC Trx crystal structure (PDB code: 2TRX) and 
EC TrxR crystal structure (FR conformation) (PDB code: 1F6M) were used as templates to build 
the DR Trx1 model and the DR TrxR model (FR conformation) respectively. Sequence identities 
are 34% (Trx) and 38% (TrxR) respectively. Side chains of the DR TrxR model (FR 
conformation) were manually adjusted to match those of the DR TrxR structure (PDB code: 
2Q7V) using COOT. Since DR Trx1 has been suggested to be more similar to a classic Trx2 
(Obiero et al, 2010) than Trx1, a second model using R. capsulatus Trx2 (31% sequence identity) 
was constructed for comparison purposes (PDB code: 2PPT). The overall quality of the three 
models was checked by PROCHECK (Laskowski et al, 1993). 
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2.12 PROTEIN­PROTEIN DOCKING 
 
A number of algorithms have been developed for initial stage of docking (rigid-body docking); 
including ZDOCK, HEX, FTDock, DOT, DARWIN, and BiGGER (Chen et al, 2003). Most of 
these algorithms search for the binding modes based on shape complementarity and electrostatics 
(Chen et al, 2003). Rigid-body docking simulations were done using the ZDOCK server 
(http://zdock.bu.edu/) with constraints based on the EC TrxR/Trx complex structure (Trx-binding 
residues were maintained at the interface). The three models (TrxR, Trx1, and Trx2) were used 
to generate two DR TrxR-Trx complexes.  Interacting partners were first placed at a reasonable 
binding orientation using PYMOL based on the E. coli TrxR-Trx complex structure, and then 
ZDOCK was used to find the final binding mode. The top complex models (best ZDOCK score) 
were compared to the EC TrxR/Trx complex structure for correctness and then used for shape 
and complementarity evaluation. Various complexes in Table 3.4 were generated in a similar 
manner. 
2.13 CALCULATION OF INTERACTION ENERGIES 
 
The DR TrxR-Trx complex was minimized using SYBL8.0 implementation of the AMBER7 
F99 force fields. A convergence criterion of a minimum energy change of 0.05 kcal-1.mol-1.Å-1 
was used. The dielectric model consisted of a distance-dependent dielectric constant with the 
distance cutoff set to 8Å and an ε value of 4.0. AMBER force fields account for forces from van 
der Waals interactions, bond stretching, bond angles, dihedral (torsion) angles, electrostatics, and 
solvation.  
 
Etotal = Ebond + Eangle + Etorsion + Evdw + Ecoulombic (1) 
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The interaction energy was calculated as the difference between interaction energies of the 
complex and of uncomplexed TrxR and Trx, using AMBER force fields. 
 
Interaction energy = energy of complex – energy of uncomplexed TrxR –  
                                 energy of uncomplexed Trx (2) 
 
DR TrxR interface residues that were deemed as important for interaction (M84A, K131A, 
F148A, and F137A), were mutated to alanine using the Biopolymer module of SYBL8.0. The 
resulting mutants were then minimized and interaction energy was calculated as described for 
wild-type complex. The difference in interaction energy (∆Interaction energy) between the wild-
type complex and each mutant complex was then calculated as: 
 
∆Interaction energy = Interaction energy (mutant) – Interaction energy (wild type) (3) 
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CHAPTER THREE: RESULTS AND DISCUSSION 
3.1 PROTEIN OVER­EXPRESSION, PURIFICATION AND CHARACTERIZATION 
3.1.1 Protein Over­Expression and Purification 
 
Trxs from E. coli and D. radiodurans, and TrxR from D. radiodurans were cloned into a 
modified pET-30b vector, which can over-express proteins fused to an N-terminal hexa-histidine 
tag. All three proteins were thus purified by immobilized metal ion affinity chromatography 
(IMAC) and found to be highly pure after single step purification, as judged by SDS-PAGE 
analysis (Figure 3.1). EC TrxR and HP TrxR in the ampicillin-resistant vector PROK-1 were 
over-expressed and purified using ion exchange and affinity chromatography, as described in the 
Materials and Methods section.   
 
 
Figure 3.1: SDS-PAGE of purified samples of various TrxR and Trx proteins. (1) EC Trx (2) 
DR Trx1 (3) LMW marker (4) EC TrxR and (5) DR TrxR. 
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3.1.2 Estimation of Protein Concentration 
 
After purification, the proteins were dialyzed and concentrated as described in the Materials and 
Methods section. The concentration of the pure protein samples was determined by the Bradford 
assay (Bradford, 1976) using bovine serum albumin as a standard (Table 2.2). All the proteins 
typically yielded 10 mg of pure protein from a 1 L culture. The proteins were subsequently 
aliquoted into PCR tubes (100µL), flash-frozen in liquid nitrogen, and stored at – 80oC. 
3.2 ENZYME KINETICS 
3.2.1 Activity Dependence on Cofactor Concentration 
 
Various NADPH concentrations have previously been used (10-500 µM) to perform NADPH 
reduction and insulin reduction assays (Holmgren & Morgan, 1976; Luthman & Holmgren, 
1982). Therefore in order to find the optimum amount of NADPH needed for our assays (insulin 
reduction and DTNB reduction assays described in section 2.6), initial velocities were measured 
with various concentrations of NADPH (10-800 µM). The DTNB assay showed saturation at 100 
µM of NADPH, but there was an unexpected drop of initial velocity with the insulin reduction 
assay above 200 µM of NADPH. No activity could be observed with the insulin reduction assay 
above 600 µM NADPH (Figure 3.2).   
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Figure 3.2: A plot of initial velocities vs. cofactor concentration for insulin reduction assay. 
Initial velocities were measured by monitoring co-factor oxidation at 340 nm under assay 
conditions described in Materials and Methods section. When increasing amounts of NADPH 
were used, there was an increase in activity up to a concentration of 0.1mM adding NADPH 
above 0.1mM results in a decrease in activity. 
 
This does not appear to be a result of substrate inhibition, because substrate inhibition in most 
cases is partial inhibition i.e. does not approach zero even at high substrate concentrations (Lin et 
al, 2001). Since this trend was only observed with the insulin reduction assay, the possibility that 
the observed inhibition was the result of interference of insulin/Trx interaction by 
NADP/NADPH was tested, using the insulin precipitation assay (Figure 3.3). Carrying out the 
insulin precipitation assay in the presence of 0.1 mM NADP or 0.1 mM NADPH (0.1 mM was 
the NADPH concentration used for all the enzymatic assays) does not result in any inhibition of 
the assay (Figure 3.3). Another possibility is that in the presence of insulin and at high NADPH 
concentrations, there is alteration of the FO/FR equilibrium of TrxR leading to inhibition. 
However, it is not clear why this trend would only be observed with the insulin reduction assay. 
Nevertheless, it was determined that 0.1 mM is the optimum NADPH concentration for both 
assays. 
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                            A) 
 
                            B) 
 
Figure 3.3:  Plot of DTT dependent reduction of bovine insulin; in the absence of NADPH (A) 
or the presence of NADPH (B). The insulin precipitation assay was carried out by addition of 
5µM of Trx1 to a reaction mixture containing 0.85mM insulin and 1mM DTT in 50mM 
potassium phosphate buffer pH 7.5. 
3.2.2 Activity of DR Trx1 
 
All Trxs reported so far can effectively reduce insulin disulfides. Upon reduction, the A and B-
chain of insulin dissociate, resulting in aggregation and precipitation of the B-chain. The 
resulting turbidity can be used to measure the activity of Trx. The standard insulin precipitation 
assay was performed as previously described (Holmgren, 1979), to confirm the identity of DR 
Trx1. The addition of 5 μM of DR Trx1 to the reaction mixture described above resulted in the 
precipitation of insulin after 16 minutes, confirming the identity of the protein. The results 
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suggest that DR Trx1 reduces insulin in a similar manner to EC Trx1 (7.8 μM of EC Trx1 
resulted in rapid precipitation of insulin after 9 minutes) (Holmgren, 1979). Examination of the 
completed D. radiodurans genome revealed two Trxs; annotated as Trx and Trx1 (White et al, 
1999). Several other bacteria also contain at least two Trxs usually designated as Trx1 and Trx2. 
In a classic Trx system, Trx2 has slightly lower redox activity than Trx1 and contains extra N-
terminal cysteines (Figure 3.4) which have been suggested to play a role in regulating Trx 
activity (Miranda-Vizuete et al, 1997).  
 
 
 
Figure 3.4: Sequence alignment of Trxs from E. coli and D. radiodurans. The N-terminus of D. 
radiodurans Trx1 is more similar to E. coli Trx2 than E. coli Trx1. Absolutely conserved active 
site cysteines are shown in blue (*) whereas N-terminus conserved cysteines of D. radiodurans 
Trx1 and E. coli Trx2 are shown in red (*).The figure was produced using the program ClustalW 
version 2.0 (Larkin et al, 2007) and the ESPript server (Gouet et al, 2003). 
 
The extra N-terminal cysteines (CxxC motifs) have been shown to act as zinc fingers in at least 
one Trx2. However the role of these zinc binding motifs is not clear, as deletion of these zinc 
fingers does not affect the oxidoreductase activity of Trx2 (Ye et al, 2007). DR Trx1 contains 
extra N-terminal cysteines whereas DR Trx does not have any cysteines on the N-terminus; 
suggesting DR Trx1 is more similar to classic Trx2 than Trx1. 
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3.2.3 Steady­state Kinetic Analysis of DR TrxR and DR Trx1 
 
The interactions between DR TrxR and Trx1 were analyzed by steady state kinetics using the 
two enzymatic assays described in the Materials and Methods section. The redox activity of the 
E. coli thioredoxin system was also determined for comparison purposes. 
(i) Insulin Reduction Assay: This assay examines the ability of thioredoxin to act as a 
substrate for the reduction of the enzyme thioredoxin reductase. The reaction is 
monitored by observing the disappearance of NADPH absorbance at 340 nm (Figure 
3.5).  
(ii) DTNB Reduction Assay: This assay is similar to the insulin reduction assay except 
that DTNB is used as the final recipient of electrons, instead of insulin. The reaction 
is monitored by measuring the reduction of DTNB at 412 nm (appearance of TNB). 
 
Figure 3.5: Illustration of the flow of reducing equivalents from NADPH to insulin or DTNB. 
The electron flow is shown for both insulin and DTNB reduction assays. 
 
Both assays are known to have some limitations; DTNB inactivates rat TrxR in the presence of 
Trx (Luthman & Holmgren, 1982) and HP TrxR reduces insulin even in the absence of Trx 
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(Pervin, 2006). Fortunately, none of these problems were observed with the E. coli or the D. 
radiodurans Trx system. Therefore, both assays were used for kinetic analysis.  
A sample saturation curve is shown in Figure 3.6 and the kinetic data are summarized in Table 
3.1.  The values for Km and Vmax were estimated by a non-linear regression fit of the Michaelis-
Menten plot where 
            v =      Vmax [S]            
                       Km + [S]    (5) 
using the Prism software (GraphPad, Software Inc.). There is a slight difference (two fold) 
between the Km values of D. radiodurans Trx system (5.7µM) and E. coli Trx system (2.7µM). 
There are also slight differences in the overall catalytic efficiency (kcat/ Km) of the two Trx 
sytems; the E. coli Trx system shows a higher (two to six fold) catalytic efficiency (1.3 x 106 M-1 
s-1) than the D. radiodurans Trx system (1.9 x 105 M-1 s-1). These results suggest that abundance 
rather than efficiency of some ROS scavenging enzymatic systems may be responsible for the 
higher ROS scavenging ability seen in D. radiodurans cell extracts compared to E. coli cell 
extracts (Tian et al, 2007). 
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Figure 3.6: Michaelis–Menten plot of DR TrxR using DR trx1 as substrate. The reaction was 
monitored by consumption of NADPH via a decrease in absorbance at 340 nm. Initial velocity 
was measured as µmoles of NADPH consumed per minute. Reaction mixtures contained 100 
mM HEPES buffer (pH 7.4), 2 mM EDTA, 30 µM solution of bovine insulin (Sigma), 0.1 mM 
NADPH (Calbiochem), 0.1 µM DR TrxR and DR Trx1 (0-35 µM). 
 
 
Assay Km (µM) kcat (s-1) kcat/Km (M-1 s-1) 
DR TrxR/DR Trx1 5.7 ± 1.9 
(2.75 ± 0.40) 
1.1 ± 0.1 
(9.4 ± 1.0) 
1.9 × 105 
(3.4 ×106) 
DR TrxR/EC Trx1 32.4  ± 8.5 18.0 ± 2.6 5.5×105 
EC TrxR/DR Trx1 44.4 ± 5.5 4.6 ± 0.2 1.0 × 105 
EC TrxR/EC Trx1 2.7 ± 0.7 
 (0.7 ± 0.003) 
3.6 ± 0.01 
(4.4 ± 0.04) 
1.3 × 106 
(6.3×106) 
 
Table 3.1: Kinetic constants for D. radiodurans Trx system. Both DR trx1 and EC Trx1 are used 
as substrates. The kcat values for the E. coli system clones are about six fold lower than the 
literature values; using both the insulin reduction and DTNB reduction assays (in brackets) 
(Holmgren & Morgan, 1976; Luthman & Holmgren, 1982). 
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3.2.4 Cofactor Specificity 
 
It has been reported that DR TrxR may have dual co-factor specificity, i.e. it can utilize NADPH 
or NADH for its redox activity. In that study, the DTNB reduction assay was performed on cell 
free extracts from D. radiodurans, without purification of either TrxR or Trx (Seo & Lee, 2006). 
To test the possibility that DR TrxR has dual cofactor specificity, the insulin reduction assay was 
performed using both NADPH and NADH as a source of reducing equivalents as described in 
the Materials and Methods section. We determined that DR TrxR can only utilize NADPH as a 
source of reducing equivalents. No activity was seen when NADH was used as a reductant for 
the insulin reduction assay (some trace activity was seen with the DTNB reduction assay) 
(Figure 3.8). Sequence analysis of DR TrxR also suggests NADPH-dependence (Figure 3.7). DR 
TrxR has the GXGXXA motif (common in NADPH-dependent enzymes) instead of the 
GXGXXG motif (common in NADH-dependent enzymes). Our results are consistent with 
previous studies which showed that bacterial TrxRs had no activity (Baker et al, 2001a) or very 
low activity (Thelander, 1967) when NADH is used. Therefore, it can be concluded that the 
DTNB reduction observed from D. radiodurans cell free extracts is probably due to a source 
other than the D. radiodurans TrxR. 
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Figure 3.7: Sequence alignment of DR TrxR and EC TrxR. The conserved active-site cysteine 
residues are indicated with green asterisks, the key residues involved in interaction with Trx are 
indicated with blue asterisks, and the GXGXXA motifs are indicated with red asterisks. The 
figure was produced using the program ClustalW version 2.0 (Larkin et al, 2007) and the ESPript 
server (Gouet et al, 2003). 
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A) 
 
 
B) 
Figure 3.8: Insulin reduction assay using NADPH or NADH as the cofactor. A) NADPH used as 
cofactor B) NADH used as cofactor. No oxidation of cofactor was observed when NADH was 
used as a reductant. 
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3.3 CRYSTALLIZATION 
3.3.1 Crystallization of DR TrxR 
 
Crystals appeared in several conditions after 3 days using sitting drop crystallization technique. 
After optimization, the best crystals were obtained in 35% (w/v) polyethylene glycol (PEG) 
4000, 0.2 M ammonium acetate, 0.1 M citric acid buffer, pH 5.1, with dimensions of 0.3 x 0.3 x 
0.5 mm (Figure 3.9) after 2 weeks. These crystals diffracted to 2.4 Å, at the in-house X-ray 
diffraction facility at the Saskatchewan Structural Sciences Center (SSSC) (DX8 Proteum 
diffractometer). They were deemed highly diffracting crystals; therefore, no further optimization 
was attempted. In addition, no cryoprotectant was needed during flash freezing with liquid 
nitrogen, because no water rings were observed in the diffraction pattern (Figure 3.11). The final 
high resolution diffraction was carried out at beamline 14-BM-C of the APS, at Argonne 
National Laboratory (Argonne, IL, USA). 
 
              
Figure 3.9: The picture of DR TrxR crystal with dimensions of 0.3 x 0.3 x 0.5 mm (Obiero et al, 
2006). 
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3.3.2 Crystallization of HP TrxR 
 
Initial HP TrxR crystals were also obtained from commercial sparse-matrix broad screens 
(Qiagen), under conditions described in the Materials and Methods section. These crystals 
initially diffracted to 3.0 Å at the Canadian Light Source. HP TrxR crystals underwent more 
extensive optimization compared to DR TrxR crystals. Optimization for HP TrxR included 
varying precipitant concentrations (ammonium sulfate), additives, temperatures, and 
crystallization methods (vapor diffusion and microbatch). After optimization, large crystals (0.2 
mm x 0.2 mm x 0.3 mm) with sharp edges (Figure 3.10) were obtained in one week at 4 ºC with 
the hanging drop crystallization technique. The best crystallization condition contained 0.2M 
ammonium nitrate, 0.2M spermine, and 2.0M ammonium sulfate. These crystals diffracted to 2.4 
Å at the Canadian Light Source. 
                                                              
Figure 3.10: The picture of HP TrxR crystals. The crystals were grown by hanging drop vapor 
diffusion crystallization method using 0.2 M ammonium nitrate, 0.2 M spermine, and 2.0 M 
ammonium sulfate at 4ºC.  
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3.4 DATA COLLECTION AND PROCESSING 
 
Data collection and processing for HP TrxR and DR TrxR was performed as described in the 
Materials and Methods section. Using the Rmerge values and the self rotation function from 
MOLREP (Vagin & Teplyakov, 1997), the space group for both DR TrxR and DR TrxR crystals 
was determined to be P3221. Matthews coefficient calculations (Matthews, 1968) suggested the 
presence of a dimer in the asymmetric unit of the DR TrxR crystals (with 47.0% solvent content) 
and a trimer in the asymmetric unit of HP TrxR crystals (with 60.0% solvent content). A 
summary of crystallographic data statistics is shown in Table 3.2. 
 
                                       
Figure 3.11: A 0.5º oscillation image collected at the APS at 100 K temperature from a D. 
radiodurans TrxR crystal. 
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     HP TrxR  DR TrxR 
     CLS   APS 
Data collection 
Temperature (K)    100K      100K 
Wavelength (Å)    1.4      0.98 
Space Group     P3221      P3221 
Unit Cell parameters (Å)   a= 89.3, b= 89.3, c= 280.3   a= 84.3, b= 84.3, c= 158.9 
     α=β=90, γ=120     α=β=90, γ=120     
Resolution limits (Å)              39.56-2.4 (2.66-2.43)           80.06–1.90 (2.00–1.90) 
Total number of reflections  524256 (116967)    311938 (43600) 
Number of unique reflections  49803 (11595)    49077 (6865) 
Completeness (%)   100 (99.6)                             93.6 (90.6) 
Rmerge (%)    4.9 (17.0)                              6.9 (33.2) 
I/σI      24.3 (7.2)                              21.6 (4.5) 
Redundancy    10.6      6.4 
Matthews coefficient (Å3  Da-1)   3.1      2.3  
 
Refinement 
Rfactor (%)                                           18.0      19.2 
Rfree                                                      25.0      24.2 
Solvent content (%)   60.6      47.2 
Number of molecules in       
asymmetric unit    3      2 
Number of atoms 
      Protein                 7072      4728    
      Ligand (FAD)                159      106 
Number of water molecules               484      521 
Overall B values                 39.0      22.0 
Average B values     
      Main chain    37.2      19.6 
      Side chains     40.1      23.0 
      Waters    45.9      40.4 
r.m.s deviations 
      Bond lengths (Å)   0.026      0.016 
      Bond angles (o)   2.3      1.7 
Ramachandran plot, 
 non-glycine residue in 
      Most favourable region (%)                     86.7      89.5 
      Additionally allowed region (%)              12.3      10.2 
      Generously allowed region (%)                 1.0      0.20 
      Disallowed region (%)                               0.0      0.20 
 
*Values in parentheses are for highest resolution shell. 
 
Table 3.2: Data collection and refinement statistics for DR TrxR and HP TrxR 
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3.5 STRUCTURE DETERMINATION 
 
Molecular replacement was used for structure determination of both DR TrxR and HP TrxR. 
Two programs were used for molecular replacement, Phaser (McCoy et al, 2007) and Molrep 
(Vagin & Teplyyakov, 1997) both which are now part of an automated scheme for molecular 
replacement by use of multiple proteins (MrBUMP) (Keegan & Winn, 2008). Both programs 
arrived at the correct solution. The rotation function of both Phaser and Molrep generates a large 
number of different orientations (see Section 1.4.6). These orientations are described by Euler 
angles.  Eulerian angles are usually described by operational order: angle α around the z axis, an 
angle β around a new y axis, and finally an angle γ around the new z axis. The two programs 
utilize different approaches for the rotation and translation functions. Molrep uses traditional 
rotation and translation functions, first proposed by Crowther and Blow (Crowther and Blow, 
1967), with some additional features (like the packing function) that provide additional 
discrimination between correct and incorrect solutions. Phaser on the other hand, uses maximum 
likelihood techniques for rotation and translation functions. For moderately or highly 
homologous structures where the probability distributions of molecular replacement solutions are 
Gaussian (as was the case with DR TrxR and HP TrxR structures) Phaser and Molrep will give 
similar results. In cases where there is poor homology between known and unknown structures, 
other probability distributions may exist. In these cases, Phaser will yield superior results to 
Molrep (because it weights models based on correctness of the model as judged from parameters 
derived from known protein structures). The correct solution is identified by Z-scores and log 
likelihood gains (LLG) in Phaser (Drenth, 1999; McCoy et al, 2007). 
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3.5.1 DR TrxR Structure Determination 
 
The DR TrxR structure was determined using chain B of the M. tuberculosis TrxR structure 
(Protein Data Bank (PDB) code 2A87) as the search model for molecular replacement (Obiero et 
al, 2006). The correctness of the resulting solution was confirmed from the electron density of 
FAD (which appeared in the expected positions although it was omitted from the initial search 
model) (Figure 3.12).  
 
Figure 3.12: Electron density map of the initial solution generated by MrBUMP. Difference map 
(Fo - Fc) generated from the molecular-replacement solution from MrBUMP. The difference 
map (coloured green) is contoured at 2.8σ. The actual model is shown as yellow lines, while the 
FAD (not included in initial model, but inserted to show location) is shown as a stick model. The 
figure was generated using PyMOL (DeLano, 2002a). 
 
Initial restrained refinement carried out using REFMAC5 (Murshudov et al, 1997) as part of 
MrBUMP (Keegan & Winn, 2008) resulted in an Rfree of 0.431, from an initial Rfree of 0.547. 
Further refinement was performed using REFMAC5 with manual rebuilding using Coot (Emsley 
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& Cowtan, 2004). Tight non-crystallographic symmetry restraints for the main-chain atoms and 
loose restraints for the side chain atoms were applied in the late stages of refinement. FAD was 
easily modeled into positive difference electron density at the expected sites. The program 
ARP/wARP (Perrakis et al, 1997) was used to add water molecules and the resulting model 
manually inspected for correctness using Coot. 
3.5.2 HP TrxR Structure Determination 
 
The HP TrxR structure was determined as described for the DR TrxR structure, except that the 
EC TrxR (PDB code 1TDE) was used as the search model. The Fo-Fc map of the initial solution 
also showed positive density for FAD, although it was omitted in the initial search model. Initial 
restrained refinement carried out using REFMAC5 as part of MrBUMP resulted in an Rfree of 
0.471 from 0.537. Further refinement and model building was carried out as described for the 
DR TrxR structure (Obiero et al, 2006) (Section 3.5.1.). 
3.6 MODEL BUILDING, REFINEMENT AND VALIDATION 
 
All refinement programs use constraints or restraints (bond lengths, bond angles, dihedral angles, 
and planarity) based on small molecule crystal structures or high resolution protein structures. 
The use of small molecule parameters is based on an assumption that proteins will have the same 
parameters as small molecule crystal structures. In constrained (rigid body) refinement, only 
overall translation and rotation can be varied (by varying dihedral angles). This reduces the 
number of parameters to be refined, but makes it easier to move large parts of the structure. In 
contrast, restrained refinement allows other parameters such as bond lengths, bond angles, and 
van der Waals contacts to vary (around a standard value), in addition to the dihedral angles. This 
makes it easy to move small parts of the structure but difficult to move large parts of the 
structure.  
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The aim of all refinement procedures is to obtain a refined structure where the deviation from 
ideal values is within an acceptable range. Refinement procedures (for the initial models from 
MrBUMP) were done using a maximum likelihood refinement program, REFMAC5, first with 
rigid body refinement (20 cycles) followed by several rounds of restrained refinement. The 
restrained refinement process was interspersed with manual rebuilding using COOT. Tight non-
crystallographic symmetry restraints for the main-chain atoms and loose restraints for the side 
chain atoms were applied in the late stages of refinement. FAD was easily modeled into positive 
difference electron density at the expected sites using Fo-Fc electron density map. The program 
ARP/wARP was used to add water molecules and the resulting model manually inspected for 
correctness using COOT. The final model was examined for the main chain torsion angles (φ, ψ) 
by the program PROCHECK (Laskowski et al, 1993). A Ramachandran plot produced by 
PROCHECK is shown in Figures 3.14 and 3.16. Except for DR TrxR’s glutamate 271 and the 
glycine residues, all of the amino acid residues are in the allowed or generously allowed regions. 
The refinement and final model statistics for the final models are shown in Table 3.2. 
3.7 THIOREDOXIN REDUCTASE STRUCTURES 
3.7.1 Oxidized DR TrxR Structure 
 
The structure of oxidized DR TrxR was refined to a 1.9Å resolution. The final restrained 
refinement resulted in an overall crystallographic R-factor of 19% and an Rfree of 24%. All the 
residues of the polypeptide chain of both subunits (A and B) were well defined in the electron 
density maps except for terminal residues of both the C-terminal and the N-terminus. One 
residue from the N-terminus and 11 residues from the C-terminus were not observed in electron 
density for subunit A and five residues from the N-terminus and 11 residues from the C-terminus 
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were not observed in the electron density for subunit B. The FAD molecules were also well 
defined in the electron density for both subunits (A and B).  
 
 
 
Figure 3.13: Electron density map (2fo-Fc map) of the active site disulfide in the FO 
conformation. In the FO confirmation, the active site disulfide is close to the isoalloxazine ring 
of FAD. Under oxidizing conditions the isoalloxazine ring of FAD is flat. 
 
The active site residues are located on a loop that connects a β-strand and an α-helix (loop β8–α3 
contains the first active-site cysteine residue C142, and helix α3 contains the second cysteine 
residue Cys145) (Figure 3.18). The electron density map of the active site disulfide (C142, 
C145) is shown in Figure 3.13. The stereochemistry of the model is good as judged by the 
Ramachandran plot (Figure 3.14). About 90% of the residues lie within the most favored region 
of the Ramachandran plot, with the rest of the residues in the additionally allowed regions of the 
Ramachandran plot. One residue (E271) is well defined in the electron density maps, but it is in 
the disallowed region of the Ramachandran plot. This residue is part of a tight turn (γ-turn) 
involving three residues D270, E271, and I272. These three residues are not conserved (Figure 
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3.18) across bacterial TrxRs and there is no apparent biological role for the tight turn. The 
residue (E271) participates in dimer formation just like the equivalent residue from HP TrxR 
(F267) which also participates in dimer formation although it is part of a loop (Figure 3.20). The 
asymmetric unit contained two monomers forming a homodimer as found in solution. The final 
results of the refinement are given in Table 3.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: The Ramachandran plot of DR TrxR. Residues in most favored regions (red), 
additional allowed regions (deep yellow), and generously allowed regions (light yellow) are 
89.7%, 10.0%, and 0.2% respectively All the residues lie within the most favored or additionally 
allowed regions except glutamate 271 which is a tight turn involving three residues D270, E271, 
and I272 (Obiero et al, 2010).  
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Overall the two monomers are very similar (they superpose with a root mean square deviation 
(rmsd) of 0.45 Å), but several loop regions show slightly different conformations, with the 
largest shift of 2.5 Å found at residue 229. Each monomer is composed of two domains, the 
FAD-binding domain (residues 1 to 123 and 249 to 325) and NADPH-binding domain (residues 
124 to 248). Both domains consist of variants of the canonical nucleotide binding fold that was 
first seen in glutathione reductase (Schulz et al, 1978). A typical Rossman fold consists of a 
slightly twisted parallel β-sheet surrounded by α-helices on both sides. However, the FAD-
binding and NADPH-binding domains of DR TrxR contain both parallel and anti-parallel β-
sheets, surrounded by α-helices on one side only. Each domain contains two β-sheets: a central 
five-stranded parallel β-sheet and a three-stranded anti-parallel β-sheet, packed against each 
other. The two β-sheets are surrounded by several α-helices on one side (Figure 3.15). 
 
Figure 3.15: The NADP(H)-binding domain of DR TrxR. Two β-sheets are surrounded by α-
helices on one side. 
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3.7.2 Oxidized HP TrxR Structure 
 
The structure of oxidized HP TrxR was refined to a 2.4Å resolution. The final restrained 
refinement resulted in an overall crystallographic R-factor of 20% and an Rfree of 26%. Unlike the 
DR TrxR where there are missing terminal residues, all 311 residues of HP TrxR are well 
defined in the electron density in all the three subunits (the asymmetric unit contained three 
monomers A, B, & C). Much like the DR TrxR, the FAD molecules were also well defined in the 
electron density for all chains. The stereochemistry of the HP TrxR model was also good, as 
judged by the Ramachandran plot (Figure 3.16).  
About 87% of HP TrxR residues lie within the most favored region of the Ramachandran plot, 
with the rest of the residues in the additionally allowed regions. The HP TrxR structure lacks the 
tight turn seen in DR TrxR; it has a loop instead. The overall structure is however very similar to 
the DR TrxR structure, with all subunits containing both the FAD and NADPH domain. Each 
domain in turn is consisted of a variant of the Rossman fold described in section 3.7.1. The final 
results of the refinement are given in (Table 3.2). Overall the three monomers are very similar 
(they superpose with an rmsd of 0.45 Å), but several loop regions show slightly different 
conformations. 
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Figure 3.16: The Ramachandran plot of HP TrxR. All the residues lie within the most favored or 
generously allowed. Residues in most favored regions (red), additional allowed regions (deep 
yellow), and generously allowed regions (light yellow) are 86.7%, 12.3%, and 1.0% respectively. 
No residues lie in the disallowed regions. 
 
3.7.3 FAD Binding 
 
The cofactor FAD is tightly but non-covalently bound to both DR TrxR and HP TrxR. All 
bacterial TrxRs characterized to date also contain tightly bound FAD. This suggests that FAD is 
incorporated during protein folding and may play a role in protein folding. A protein containing 
oxidized FAD can be easily identified by the bright yellow color of the protein solution or 
crystals. The FAD binding modes of DR TrxR and HP TrxR are similar to each other, and to 
those observed in other enzymes belonging to the pyridine nucleotide–disulfide oxidoreductase 
family. FAD binding to TrxR can be divided into three regions: the riboflavin binding region, 
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diphosphate binding region, and adenosine binding region. The FAD binding domain of bacterial 
TrxRs is divided into two parts (section 3.7.1). Most of the interactions with FAD occur within 
the N-terminal part of the FAD binding domain. The C-terminal part of the FAD domain only 
interacts with the isoalloxazine ring of the riboflavin portion of FAD.  
i) Riboflavin binding region 
n 
n 
The riboflavin binding region consists of two parts the isoalloxazine ring and a ribityl moiety. 
The isoalloxazine ring and the ribityl moiety are completely buried in the protein and are 
dominated by hydrogen bonding interactions with the main chain and side chains of two 
residues, N54 and L293 (the amino acid numbering scheme is based on DR TrxR for the 
discussion in this section; corresponding HP TrxR amino acids are shown in Figure 3.18). N54 is 
invariant and L293 has conserved substitutions. In addition, several water molecules participate 
in a hydrogen-bond network. 
ii) Diphosphate binding regio
The oxygen atoms of the diphosphate group interact primarily with main-chain nitrogen atoms, 
except for the hydrogen bond to the side chain of Q45 (Figure 3.18). It is worth noting that there 
is no positively charged residue in the immediate vicinity of the diphosphate group. Instead, the 
negative charge on the phosphate groups is stabilized by the dipole of helix α1 and hydrogen 
bonding to the main-chain nitrogen atoms. Water molecules also participate in the hydrogen-
bond network. 
iii) Adenosine binding regio
The adenosine binding region is composed of two parts, an adenine and a ribose sugar binding 
regions. The adenine ring binds in a pocket formed by residues G15, E86, V87, N250, and F253; 
but does not form any hydrogen bonding with any main chain or side chain atoms except 
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between the main chain oxygen of V87 and the amine of the adenine ring (Figure 3.17). Both 
hydroxyl oxygen atoms of the adenosine ribose form hydrogen bonds with the carboxyl group of 
E38. Although residue E38 is not conserved (Figure 3.18), it has been observed that all bacterial 
TrxRs form H-bonds with both hydroxyl oxygen atoms of the adenosine ribose (Figure 3.17). In 
EC TrxR for example, hydrogen bonding to both hydroxyl groups is formed by side chains of 
S14 and T36. This feature has been observed in many nucleotide-binding proteins (Karplus & 
Schulz, 1989; Mattevi et al., 1992), but not in mammalian TrxR, where there is only one 
hydrogen bond formed with the adenosine ribose.  
 
E86
V87
N250
Q45
N54
E38
N54
Q45
N250
E38
E86 V87
F253F253
2.8 Å 2.8 Å
2.6 Å 2.6 Å
 
 
 
 
Figure 3.17: Stereoview of key residues that interact with FAD in the DR TrxR structure. 
Residues N250, F253, V87, and E86 form a binding pocket for adenine ring and E38 forms 
hydrogen bonds with both hydroxyl oxygen atoms of the adenosine ribose. 
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Figure 3.18: Sequence alignment of various TrxRs showing thioredoxin binding, nucleotide 
binding, and dimer formation residues. Invariant residues are highlighted by a red background. 
The secondary structure of D. radiodurans TrxR assigned by the ESPript server is shown on the 
top line. Possible functions of individual residues are indicated on the bottom line with asterisks: 
FAD-binding (red), NAD(P)H-binding (pink), dimer formation (cyan), and Trx-binding (blue). 
The numbers on the top line represent D. radiodurans amino acids. The figure was produced 
using the program ClustalW and the ESPript server. 
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3.7.4 NADPH binding 
 
The binding mode of NADPH has been determined in several bacterial TrxR structures; both in 
the FO conformation and the FR conformation of the enzyme. The binding mode is similar in 
both conformations, i.e. NADPH-protein interactions, despite the fact that the orientation of the 
NADPH-binding domain relative to the FAD-binding domain is very different in both 
conformations. However there are small differences between the NADPH-binding modes of FO 
and FR conformations. NADPH is more exposed to solvent in the FO conformation than in the 
FR conformation. The NADPH binding residues are mostly conserved among bacterial TrxRs 
(Figure 3.18). Among the conserved residues, there are three invariant arginine residues (DR 
TrxR residues: R183, R184, and R188) that bind the 2’-phosphate of NADP (hydrogen bond/salt 
bridges). These three residues may be responsible for the ability of bacterial TrxR reductases to 
discriminate between NADPH and NADH (Gustafsson et al., 2007).  
The HP TrxR structure (PDB code: 3ISH) (without NADP) appears to be remarkably similar to 
other HP TrxR structures (with NADP bound PDB codes: 2Q0L, 2Q0K; Gustafsson et al, 2007) 
despite the presence of the additional molecules (NADP) in other HP TrxR structures. All the Cα 
atoms of our HP TrxR (3ISH) can be superposed to those of NADP-bound HP TrxR structures 
(2Q0L, 2Q0K) with an rmsd of ~0.4 Å. NADPH-binding does not alter the main chain, however, 
the side chains involved in interaction with 2’-phosphate of NADPH have different orientations 
compared to those of NADP-bound HP TrxRs (Figure 3.19). Overall the HP TrxR NADPH 
domain has higher temperature factors (43 Å2) compared to the FAD domain (35 Å2). The 
disparity of temperature factors in bacterial TrxRs is thought to be due the flexibility of NADPH 
domain, which is in equilibrium between the FO and FR conformations in solution (Akif et al, 
2005).  
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Figure 3.19: HP TrxR structures showing NADPH diphosphate binding residues. HP TrxR 
structures are superposed and shown with NADPH (Red) and without (Blue) NADPH. 
 
 
 
 
 
 
 
82 
 
  
 
3.7.5 Dimer Interface 
 
Bacterial TrxRs are homodimers in solution. The asymmetric unit of DR TrxR contained a dimer 
whereas the asymmetric unit of HP TrxR contained a trimer (consisting of the correct biological 
dimer and a monomer which generates a dimer across the two-fold of the P3221 space group 
given the correct transformation matrix) (Figure 3.20). Unlike eukaryotic TrxR, which has an 
interface domain that facilitates dimerization, bacterial TrxR utilizes residues from both NADPH 
binding domain and FAD binding domain for dimerization. Residues that participate in the 
dimerization of bacterial TrxR were identified (Figure 3.18) by visual inspection of the interfaces 
and by analysis using various servers (Proface and Robetta)  
(http://www.boseinst.ernet.in/resources/bioinfo/stag.html; 
http://robetta.bakerlab.org/alascansubmit.jsp). 
Most of these residues are conserved or contain conservative substitutions across bacterial TrxRs 
(Figure 3.18). The interface contains almost an equal number of polar (including charged 
residues) and non-polar residues. However, the Robetta server predicts that non-polar residues 
contribute more to interface stability than hydrophilic residues, as evidenced by higher ∆∆G 
values upon mutation to alanine. This prediction is consistent with PDB surveys (of other 
permanent complexes) which suggest that hydrophobic effects play the dominant role in 
interface stability of most protein complexes (Jones & Thornton, 1996; Moreira et al, 2007; 
Young et al, 1994).  
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A) 
 
B) 
 
Figure 3.20: A) Stereo ribbon representation of the dimer of DR TrxR. Bound FAD molecules 
are shown in stick representation. Subunits are colored by domain organization, with the FAD-
binding domains in red and cyan and the NAD(P)H-binding domains in green and magenta. B) 
The HP TrxR crystallographic symmetry dimer (colored red and blue) generated by applying a 
transformation matrix (found in remark 350 from PDB code: 3ISH) to the monomers across the 
two-fold of the P3221 space group. The other dimers (non-crystallographic symmetry) are shown 
cyan and magenta. Crystallographic and non-crystallographic symmetry dimers are equivalent. 
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A 
 
B 
 
Figure 3.21: HP TrxR and DR TrxR dimer interface. A) Interactions of residue F267 in the 
dimer interface of HP TrxR. The two subunits are indicated in different colors (red and 
magenta). B) Interactions of the Ramachandran outlier, residue E271 in the dimer interface of 
DR TrxR. The two subunits are also indicated in different colours (red and magenta). 
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3.7.6 Comparison with other Bacterial TrxR Structures 
 
Crystal structures of several oxidized bacterial TrxRs have been determined to date; those 
discussed in this thesis and those from M. tuberculosis and A. thaliana (Gustafsson et al, 2007). 
They all share moderate sequence identity (DR TrxR and HP TrxR show 44% and 37% sequence 
identity with EC TrxR respectively) and superposition of their three-dimensional structures 
shows that their overall folds are similar (Figure 3.22). Sequence alignment of the LMW TrxRs 
with known three-dimensional structure together with the secondary structural elements of DR 
TrxR (Figure 3.18), shows that residues from the cofactor binding sites, Trx binding sites and 
dimer interfaces are mostly conserved. Loop regions are relatively less conserved, with some 
enzymes containing insertions in the loop regions and at the N- and C- termini. Structures 
determined under reducing conditions have the same fold and same overall conformation (FO). 
However, the FAD conformation is different between reduced and oxidized structures. The 
isoalloxazine ring of FAD is flat in the oxidized structure but displays a bent “butterfly” like 
structure in the reduced structure (Gustafsson et al, 2007). The observed bending angle of 
reduced FAD varies from structure to structure. The bending angle of reduced FAD for HP TrxR 
(22º) lies within the range (15–28º) suggested by molecular-orbital calculations for reduced free 
flavins (Dixon et al, 1979), whereas that of the EC TrxR (34º) lies outside this range (Gustafsson 
et al, 2007; Lennon et al, 1999). 
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Figure 3.22: Superimposed TrxR monomers (FO conformation) from E. coli (red), D. 
radiodurans (cyan), and H. pylori (Blue); DR TrxR and HP TrxR structures superpose with the 
EC TrxR structure with rmsd values of 1.6Å and 1.7Å respectively. 
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3.8 CONFORMATIONAL STATES OF THIOREDOXIN REDUCTASE 
3.8.1 Fluorescence Spectroscopy 
 
As discussed in Section 1.2.4, LMW TrxR undergoes a large conformational change during 
catalysis. In the FO conformation the redox active disulfide is adjacent to the flavin, whereas in 
the FR conformation the NADPH binding site is adjacent to the flavin. The two conformations 
differ by a 66º domain rotation relative to each other. This domain rotation model has previously 
been successfully investigated by flavin fluorescence spectroscopy of a C138S active-site mutant 
in EC TrxR. The flavin fluorescence of this mutant is only 7% that of wild-type EC TrxR, 
presumably due to quenching by S138 in the FO conformation (S138 is close to the flavin in the 
FO conformation) (Mulrooney & Williams, 1997). An equivalent DR TrxR mutant (C145 Ser 
active-site mutant), was used to test whether DR TrxR exhibited similar quenching upon 
mutation of one of the active site cysteines to serine. The results show that DR TrxR behaves in a 
similar manner to EC TrxR (Figure 3.23) i.e. flavin fluorescence of C145 DR TrxR is much 
lower compared to the flavin fluorescence of wild-type DR TrxR (~15% of wild-type DR TrxR). 
These results suggest that domain rotation upon mutation of active site cysteines is probably 
common to DR TrxR and EC TrxR, although the trigger for domain rotation is not yet known. 
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Figure 3.23: Emission spectra of wild type DR TrxR vs C145S mutant. The large decrease in 
fluorescence suggests that the the FO mutant is predominantly in the FO conformation. 
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3.8.2 Complex Formation 
 
A covalent complex between EC TrxR and EC Trx has previously been prepared and 
characterized (Lennon et al, 2000). The crystal structure of the EC TrxR-Trx complex has been 
determined and shows that EC TrxR in this structure is “trapped” in the FR conformation 
(Lennon et al, 2000). All other crystal structures of bacterial TrxRs that have been determined to 
date are in the FO conformation. In order to compare characteristics of homologous and 
heterologous complexes, a previously described scheme (Wang et al, 1996) was used to generate 
various homologous and heterologous TrxR-Trx complexes, with the aim of determining their 
crystal structures. The following mutants were generated by site-directed mutagenesis for the 
purposes of complex formation: C142S and C145S DR TrxR; C64S and C67S DR Trx1; C28S 
and C31S HP Trx2. The complexes were formed as described in section 2.5. Trx mutants were 
first reacted with DTNB to form a mixed Trx-5-thio-2-nitrobenzoic acid (TNB) complex and 
then the final complexes formed by reacting Trx-TNB complex with TrxR active site mutant 
(Wang et al., 1996) (Figure 3.24).  
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Figure 3.24: Schematic representation of TrxR –Trx complex conformation. The mixed E. coli 
wild type TrxR/Trx disulfide is short-lived (A). Reaction of E. coli C135S TrxR with C32S Trx-
TNB disulfide results in a stable mixed TrxR/Trx disulfide (B). 
 
An alternative method was previously developed where 4,4'-dithio-dipyridine (DPDS) is reacted 
with TrxR mutant first to form a mixed TrxR-PDS complex before reaction with the Trx mutant 
for the formation of the final complex (Veine et al, 1998). Both strategies were used in an 
attempt to form the complex between DR TrxR and DR Trx1 using various combinations of 
mutants, because previously it had been shown that complexes can form from whatever 
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combinations of TrxR and Trx mutants were used. However, the attempts yielded low amounts 
of DR TrxR- DR Trx1 complex as analyzed by SDS-PAGE. The problem was probably due to 
the low solubility or low reactivity of DR Trx1. The heterologous system, DR TrxR- HP Trx2 
complex, yielded a higher amount of complex as analyzed on an SDS-PAGE (Figure 3.25).  
 
 
   1                                 2                 3 
 
Figure 3.25: SDS-PAGE of the DR TrxR-HP Trx2 complex. Lane 1 shows the Non-reducing 
SDS-PAGE and lane 2 shows the reducing SDS-PAGE of the DR TrxR-HP Trx2 complex. The 
expected molecular weights are DR TrxR-HP Trx2 complex (48 kDa), DR TrxR (36 kDa), and 
HP Trx2 (12 kDa) (too small to be seen on this gel). 
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3.9 THIOREDOXIN REDUCTASE SPECIES SPECIFICITY 
3.9.1 Cross Reactivity of the DR Trx System with the EC Trx System 
 
DR TrxR and DR Trx1 were tested for their ability to cross-react with EC Trx1 (34% sequence 
identity with DR Trx1) and EC TrxR (38% sequence identity with DR TrxR) respectively, as 
described in the Materials and Methods section. These cross-reactions are considered 
heterologous because they involve interactions between proteins of different species. The results 
are summarized in Table 3.1. Previous studies have shown that TrxRs have a higher affinity for 
cognate Trxs than for Trxs from other species (Table 3.3) (Arner et al, 1999; Oblong et al, 1993; 
Oliveira et al, 2010; Pervin, 2006). Consistent with results from other bacterial Trx systems, DR 
TrxR prefers its cognate Trx (Km, 2.7 µM) as a substrate over Trxs from different species (EC 
Trx1 Km, 10.7 µM) (Table 3.3). 
 
Protein Km for homologous Trx Km for heterologous Trx 
E. coli TrxR 2.0 µM 20.0 µM (Human Trx) 
E. coli TrxR 2.0 µM 35.0 µM (Rat Trx) 
A. thaliana TrxR 3.0 µM 80.0 µM (E. coli Trx) 
D. radiodurans TrxR 2.7 µM 10.7 µM (E. coli Trx1) 
S. cerevisiae TrxR 1.3 µM ND (E. coli Trx1) 
S. cerevisiae TrxR 1.3 µM ND (Human Trx) 
 
Table 3.3: Km values of homologous and heterologous Trx systems. Heterologous sytems have 
higher Km values compared to homologous systems. The Km values for interaction between S. 
cerevisiae TrxR and human Trx or EC Trx1 was too high to be determined. 
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The differences in specificity have been attributed to differences in the size and charge of loop 
regions of the FAD-binding domains (Oliveira et al, 2010; Zhang et al, 2009) and differences in 
the charge and shape of Trx-binding surfaces (Gustafsson et al, 2007; Obiero et al, 2010; 
Oliveira et al, 2010). However, the molecular basis of this phenomenon is still not completely 
understood (Oliveira et al, 2010). Structures of LMW TrxRs have provided useful clues about 
the basis of the species specificity phenomenon (Dai et al, 1996; Oliveira et al, 2010). Although 
the overall structure of LMW TrxRs is highly conserved (FAD and NADPH domains), there are 
significant differences in the size and type of residues found on the loop regions between 
prokaryotic and eukaryotic LMW TrxRs. Simulated TrxR-Trx complex models suggest a role for 
the loop regions in Trx binding specificity in eukaryotic LMW TrxRs.  
In contrast, there are no significant differences in loop regions among prokaryotic TrxRs. 
Moreover, the EC TrxR-Trx complex structure (PDB code: 1F6M) shows that the residues 
involved in interactions between TrxR and Trx are mainly from the NADPH binding domain and 
not at the loop regions. The basis of the species specificity within prokaryotic LMW TrxRs has 
therefore been thought to be due to the subtle differences of the NADPH domain (Gustafsson et 
al, 2007; Obiero et al, 2010). However, there has not been any systematic study of the Trx-
binding residues of prokaryotic LMW TrxRs. This is the first description of the role played by 
specific residues on the prokaryotic LMW TrxR-Trx interface. 
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3.9.2 Structural Analysis of the Trx Binding Site 
 
Our kinetic results show that DR TrxR has a lower affinity (4-8 fold higher Km) for EC Trx1 
compared to its own Trx. The structural basis of binding of EC Trx1 to EC TrxR has been 
elucidated (Lennon et al, 2000). Eight residues (G129, R130, G131, V132, S133, F141, F142 and 
Y143) on the surface of the NADPH domain of EC TrxR form a groove to which a 
complementary Trx loop binds. Two of these residues (F141 and F142) fit into a hydrophobic 
pocket on EC Trx1, making additional interactions with EC Trx1 (Lennon et al, 2000). The two 
EC TrxR residues that fit into a hydrophobic pocket on EC Trx have corresponding residues in 
DR TrxR (F148 and 149 respectively) and HP TrxR (F139 and F140). However crystal 
structures of EC TrxR, DR TrxR, and HP TrxR reveal that these residues poorly superpose and 
point in different directions (Figure 3.26). The two residues together with R130 constitute the 
largest proportion of the Trx binding site surface area. It can thus be inferred that variation in the 
shape of these residues contributes most to species specificity of TrxR-Trx recognition. All the 
eight residues that form the Trx binding groove on the EC TrxR surface are identical to those of 
DR TrxR and HP TrxR except the conserved substitution of R130 (EC TrxR) with  K137 (DR 
TrxR) or K128 (HP TrxR). This substitution also contributes to differences in the shape of Trx 
binding site (Figure 3.26).  
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Figure 3.26: Superimposed TrxR structures (FO conformation) from E. coli (red), D. 
radiodurans (cyan), and H. pylori (Blue) showing some key residues that are important for 
binding to thioredoxin. Active site disulfide is also shown.  
3.9.3 Modeling of TrxR­Trx Complex Structures 
 
A more thorough analysis of shape and complementarity differences between homologous and 
heterologous TrxR-Trx complexes could be performed if homologous and heterologous 
complexes were available. Several fundamental properties can be obtained from a crystal 
structure or homology model of a protein-protein complex including overall size, shape 
complementarity and electrostatic complementarity of the interface (Jones & Thornton, 1996). 
These properties can be used to gain understanding of transient protein-protein interactions at a 
molecular level. The most popular approach of evaluating electrostatic complementarity between 
protein-protein interfaces is to calculate electrostatic potentials of the interface using the Poisson-
Boltzmann equation (Elcock et al, 2001). Shape complementarity can be evaluated by planarity 
or gap volume index calculations (Jones & Thornton, 1996). A planarity score can be obtained 
by calculating the rmsd of all interface atoms (within 4Å of each other) from an imaginary plane 
at the centre of the interface. A lower planarity score suggests greater complementarity. The gap 
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volume index relates volume of interface cavities to the interface area. It is calculated by the 
following equation: 
 
GV (Å) = Gap volume between molecules (Å3)/Interface area (Å2) (per complex).  
 
Similar to planarity, a lower gap volume index also suggests better shape complementarity 
(Bahadur & Zacharias, 2008; Jones & Thornton, 1996).  
In the absence of complex structures, previous studies have shown that a reasonable protein-
protein complex can be modeled by protein-protein docking from two unbound protein partners 
(Chen & Weng, 2002). Since the DR TrxR-DR Trx complex structure is currently unavailable, 
docking was used to generate DR TrxR-DR Trx complex for computational analysis. Using 
homology models of Trx and TrxR (reduced conformation) and a protein-protein docking 
software (Z-DOCK), a model of the DR TrxR-DR Trx complex was generated (along with 
models of other complexes in Table 3.4).   
 
Trx system Interface area 
(Å2) 
GV Index 
(Å) 
DR TrxR/DR Trx1 1162  0.2 (2.2) 
DR TrxR/EC Trx1 1030 2.8 
EC TrxR/EC Trx1 1160 2.5 
EC TrxR/DR Trx1 1259  3.3 (2.9) 
 
Table 3.4: Surface area and gap volume indices. The values in parentheses represent indices 
from the D. radiodurans Trx1 model generated from R. capsulatus Trx2 crystal structure (PDB 
code: 2PPT). 
 
In this study, both electrostatic and shape complementarity were used to study the differences 
between homologous and heterologous TrxR-Trx interactions. Gap volume index calculations 
(Table 3.4) suggest that homologous TrxR/Trx systems show more complementarity than 
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heterologous systems. The gap volume index for EC TrxR/DR Trx complex is higher (3.3Å) than 
that of EC TrxR/ EC Trx complex (2.5Å); likewise the gap volume index for DR TrxR/ EC Trx 
complex is higher (2.8Å) than that of DR TrxR/ DR Trx complex (0.2Å). A comparison of the 
overall surface-charge distribution shows some charge complementarity between Trx and TrxR. 
The surface surrounding the Trx-TrxR complex interface is both positively and negatively 
charged in Trx as well as in TrxR. The interface itself is mostly non-polar in both Trx and TrxR. 
This complementarity is seen in all the Trx systems analyzed (E. coli, D. radiodurans, and H. 
pylori). The surface around the Trx binding site of EC TrxR was the most negative and that of 
DR TrxR was the most positive (Figure 3.27). This difference in surface charge may also play a 
role (although probably small role compared to shape) in the species specific recognition. 
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Figure 3.27 A: Electrostatic surface potentials of E. coli TrxR (top) and E. coli Trx1 (bottom) 
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Figure 3.27 B: Electrostatic surface potentials of D. radiodurans TrxR (top) and D. radiodurans 
Trx1 (bottom) 
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Figure 3.27 C: Electrostatic surface potentials of HP TrxR (top) and HP Trx1 (bottom). 
Electrostatic potentials for all the figures (A,B, and C) were calculated by APBS software (Baker 
et al, 2001b). Positively and negatively charged areas are colored red and blue and contoured at -
5 kBTe-1 and +5 kBTe-1 respectively. Key residues of the TrxR-Trx complex interface are shown 
on the diagram. The overall shape of Trx-binding site differs between the three TrxRs, but there 
are only small differences in the electrostatic potentials. The figures were generated with 
PYMOL using EC TrxR, EC Trx, DR TrxR, and HP TrxR coordinates (PDB codes 1TDE, 
2TRX, 2Q7V, and 3ISH respectively). The DR Trx1 and HP Trx1 figure were generated using 
the DR Trx and HP Trx1 homology models. 
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3.9.4 Identification of Hot Spot Residues 
 
Previous research on protein-protein interactions has shown that only a small fraction of the 
interface residues (hot spot residues) are responsible for the majority of interface stability 
(Moreira et al, 2007). Alanine scanning mutagenesis is the most widely used technique to 
identify hot spot residues. It was first used to map hot spots of binding energy in the human 
growth hormone-receptor interface (Clackson & Wells, 1995). Although slow and labor 
intensive, it has since been used to map binding hot spots for several protein-protein interfaces 
(Bogan & Thorn, 1998; DeLano, 2002; Moreira et al, 2007; Thorn & Bogan, 2001). Alanine 
scanning measures the effect of the deletion of an amino acid side chain beyond the β-carbon 
atom on the affinity of a protein-protein complex. Glycine substitutions would be ideal for 
measuring the effect of deletion of all the amino acid side chain atoms but glycine can introduce 
additional conformational freedom into the protein backbone, therefore it is rarely used (Moreira 
et al, 2007). Because experimental alanine scanning mutagenesis is slow and labor intensive, a 
computational protocol (computational alanine scanning mutagenesis) has been developed to 
map protein-protein interfaces (Kortemme et al, 2004b). The protocol uses a simple free energy 
function to calculate the effects of alanine mutations on the binding free energy of a protein-
protein complex. This technique correctly predicted 80% of protein-protein interface hot spot 
residues, when compared with experimentally observed change in binding free energy upon 
alanine substitution.  
Using this technique with the Robetta server (http://www.robetta.org/submit.jsp), three EC TrxR 
residues of TrxR-Trx complex (PDB code: 16FM) interface were predicted to be hot spot 
residues (Table 3.5). Previously it has been suggested that binding hot spots are those residues 
which show a ∆∆G larger than 1 kcal/mol (Kortemme & Baker, 2002). Only three (F81, F141 
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and F142) of the 22 residues had a predicted value of greater than 1 kcal/mol. Although its 
predicted ∆∆G was less than 1 kcal/mol, visual inspection of the EC TrxR-EC Trx interface 
suggested a significant role for R130.  Five residues form EC TrxR (D99, N100, G129, R130 and 
A237) and four residues from EC Trx (W31, E44, S95 and R73) participate in hydrogen bonding 
across the TrxR-Trx interface. Of the EC TrxR residues that form hydrogen bonds across the 
TrxR-Trx interface, Arg 130 contributes most to interface stability. The side chain of this residue 
participates in four hydrogen bonds with amino acids from Trx. It was thus deemed to also play a 
significant role in interface stability. Equivalent residues (to the four EC TrxR residues) from DR 
TrxR were then individually mutated to alanine and tested for affinity towards Trx. 
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Residue # Amino acid type
EC TrxR
Amino acid type
DR TrxR
∆∆G (complex)
kcal/mol
37 M G 0.69
38 E M 0.00
39 K P 0.04
44 T A 0.00
45 T W 0.08
81 F M 2.01
130 R K 0.78
141 F F 1.70
142 F F 3.27
82 D D -0.11
83 H E 0.24
99 D Y 0.30
100 N N 0.40
132 V V -0.01
133 S S 0.41
135 C C -0.02
137 T T 0.08
138 C C -0.59
139 D D 0.11
143 Y Y 0.56
215 M - 0.13
217 V V -0.05
 
Table 3.5: Computational alanine scanning mutagenesis results from Robetta server. Hot spot 
residues are highlighted in red. Hot-spot residues can be defined operationally as those for which 
alanine mutations have destabilizing effects on ∆∆G of more than 1 kcal/mol. Interface residues 
are defined as those residues with atoms within 4Å of the other partner. 
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3.9.5 Kinetic Analysis of Hot Spot Residues 
 
Equivalent residues (to the four EC TrxR residues highlighted in Table 3.5) from DR TrxR were 
individually mutated to alanine and tested for affinity towards Trx. All the DR TrxR alanine 
mutants showed a significant reduction in affinity compared to wild type DR TrxR when reacted 
with DR Trx1. The F148A TrxR mutant showed the greatest increase in Km (20 fold), followed 
by the F149A TrxR mutant (10 fold) and M84A TrxR mutant (8 fold). The K137A TrxR mutant 
showed the smallest increase in Km (4 fold), when compared with homologous DR Trx system. A 
similar trend was observed when the same DR TrxR mutants were cross-reacted with EC Trx1. 
The F149A TrxR mutant showed the greatest increase in Km (10 fold), followed by F148A (6 
fold) and then the K137A TrxR mutant Km (2 fold), when compared with Km values of the wild 
type heterologous cross-reaction assay (DR TrxR/EC Trx1). However, there was no significant 
change in the Km values M84A mutant and the K137R mutants in the cross-reaction assays. 
Instead both DR TrxR mutants showed an increase in the specificity constant. The results are 
summarized in Table 3.6. 
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Assay Km (µM)  kcat (s-1) kcat/Km (M-1 s-1) 
DR TrxR (wt )/DR Trx1 2.8 ± 0.4  9.4  ± 1.0 3.4 × 106  
DR TrxR M84A/DR Trx1 47.8 ± 2.7 3.2 ± 0.2 5.4 × 104  
DR TrxR K137A/DR Trx1 10.4 ± 0.9 8.9 ± 0.3 8.6 × 105  
DR TrxR F148A/DR Trx1 61.4 ± 6.7 11.0 ± 0.5 1.8 ×105  
DR TrxR F149A/DR Trx1 26.9 ± 3.3 2.2 ± 0.1 8.1 × 104  
DR TrxR K137R/DR Trx1 5.4 ± 0.4 7.2 ± 0.2 1.3 × 106 
A) 
 
Assay Km (µM)  kcat (s-1) kcat/Km (M-1 s-1) 
DR TrxR (wt )/EC Trx1  10.4 ± 1.0   2.2  ± 0.4  2.1 × 105  
DR TrxR M84A/EC Trx1 6.5 ± 0.1 11.2 ± 1.0 1.7 × 106  
DR TrxR K137A/EC Trx1 17.7 ± 4.1 7.3 ± 0.5 4.1 × 105  
DR TrxR F148A/EC Trx1 60.3 ± 4.1 6.8 ± 0.3 1.1 × 105  
DR TrxR F149A/EC Trx1 97.2 ± 7.8 2.0 ± 0.1 2.0 × 104  
DR TrxR K137R/EC Trx1 8.3 ± 0.3 10.2 ± 0.3 1.2 × 106 
B) 
Table 3.6: Kinetic parameters Trx binding site mutants of DR TrxR. Most alanine mutants 
showed an increase in Km and a decrease in specificity constants (kcat/Km) when reacted with DR 
Trx1 (A) and cross-reacted with EC Trx1 (B). The M84A mutant showed an increase in 
specificity constant when cross-reacted with EC Trx1 compared to DR TrxR (wt )/EC Trx1. 
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 The exact in vivo concentration of Trx is not known. As a result there are widely varying 
estimates of Trx concentrations (1-100µM) (Gromer et al, 2004). Regardless of the exact Trx 
concentrations in vivo the change in affinity due to the substitution of the four residues with 
alanine was large enough that there would be no meaningful interaction expected in vivo without 
the four residues. Since mutational effects have been shown to be generally additive (Qin et al, 
1995; Wells, 1990), changing the four residues to alanine would be expected to lower the affinity 
of TrxR for Trx by more than 10 000 fold. These results therefore suggest that only four residues 
are responsible for the majority of the TrxR-Trx interface stability. Of the four residues, two are 
invariant (F148, F149) across bacterial TrxR and two others have conserved substitutions (M84, 
K137) (Figure 3.18). Together these four residues can be considered to be the binding epitope of 
the TrxR-Trx interface.  
Mapping specific residues at protein-protein interfaces that contribute to the specificity and 
strength of protein-protein interactions has been a subject of intense research in the last few 
years. Alanine scanning mutagenesis has enabled detection of hot spot residues and 
demonstrated that most of the binding strength at protein-protein interfaces is due to hot spot 
residues (a small subset of interface residues) (Moreira et al, 2007). These results show that the 
TrxR-Trx interface is similar to other protein-protein interfaces, where only a small number of 
interface residues are responsible for most of the binding affinity and specificity. In addition, 
some binding hot spots interact with a variety of partners (DeLano et al, 2000); therefore, for 
proteins that interact with several partners like Trx, identifying one binding hot spot may be 
useful in studying interactions with other protein partners (Qin et al, 1995).  
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3.9.6 Comparison of Calculated TrxR­Trx Interaction Energies versus Affinities 
 
For cross validation purposes, experimentally observed changes in affinities were correlated to 
computationally calculated interaction energies. Two DR TrxR-DR Trx complex models were 
constructed for computational characterization using DR TrxR and two DR Trx models (see 
section 2.11). The two DR Trx models were constructed using EC Trx1 crystal structure and R. 
capsulatus Trx2 crystal structure. However, only the DR Trx model generated from R. 
capsulatus Trx2 crystal structure was used for calculation of interaction energies because the 
sequence of DR Trx1 suggests that its closer to Trx2 than Trx1 (DR Trx1 contains extra N-
terminal cysteines that are usually found only in Trx2 as seen in Figure 3.4). In addition, DR 
TrxR-DR Trx complex model generated using the DR Trx model constructed using coordinates 
of R. capsulatus Trx2 crystal structure showed reasonable gap volume index values (Table 3.4). 
 A comparison was done between the calculated interaction energies and experimentally 
observed affinities using the aforementioned DR TrxR-DR Trx complex model. The correlation 
coefficient value was found to be 60% (Figure 3.28) for calculated interaction energy. Consistent 
with results from previous studies, these results show that parameters like interaction energy can 
be useful in predicting and ranking hot spot residues of protein interfaces (Khoury et al, 2009; 
Kortemme et al, 2004b). Although not completely predictive, these results suggest that 
computational alanine scanning mutagenesis is a useful alternative to the labor-intensive alanine 
scanning mutagenesis analysis (for identification of hot spot residues and redesign of enzymes 
with new specificities). 
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Figure 3.28: Plot of experimental Km ratios (mutant/wild-type) vs. calculated changes in 
interaction energies (AMBER) for the DR TrxR mutants described in this study. Interaction 
energies showed reasonable correlation (R2 = 60%) with the ratio (mutant/wild-type) of 
experimental Km values. 
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3.9.7 Design of DR TrxR  for Altered Trx Specificity 
 
These computational predictions and experimental results suggest that two invariant residues 
(F148, F149) are responsible for the majority of TrxR affinity for Trx and two others with 
conserved substitutions are responsible for the majority of specificity (M84, K137). Together the 
four residues can be considered as the binding epitope of the TrxR-Trx interface. Replacement of 
DR TrxR M84 with alanine resulted in a large increase in Km for the homologous assay (DR 
TrxR M84A/DR Trx1) but decrease in Km for the heterologous assay (DR TrxR M84A/EC Trx1) 
(Table 3.6). These results implicated M84 as one of the key residues in determination of species 
specificity. The DR TrxR K137R mutant also showed an increase in the Km value for the 
homologous assay (DR TrxR K137R/DR Trx1) and a slight decrease in the Km value for the 
heterologous assay (DR TrxR K137R /EC Trx1) (Table 3.6). Therefore K137 was also 
implicated in species specificity.  
Our working hypothesis was that if all the residues of the functional epitope of DR TrxR were 
changed to match those of EC TrxR, then DR TrxR would be changed to have a higher affinity 
for EC Trx than for its own Trx. We therefore made a double DR TrxR mutant (M84F, K137R) 
and tested its affinity for DR Trx and EC Trx. The results (Table 3.7) are consistent with our 
predictions; the DR TrxR double mutant had a much higher affinity for EC Trx compared to its 
own Trx. It is worth emphasizing that, although the four residues are crucial in TrxR-Trx 
interface stability, they are insufficient in altering the specificity to match or surpass that of the 
wild-type Trx systems. This suggests a role for other factors such as overall shape and charge of 
the Trx-binding site in determining species specificity as previously suggested (Gustafsson et al, 
2007; Obiero et al, 2010). 
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Assay Km (µM)  kcat (s-1) kcat/Km (M-1 s-1) 
DR TrxR (wt )/DR Trx1 2.8 ± 0.4  9.4  ± 1.0 3.4 × 106  
DR TrxR (wt )/EC Trx1  10.4 ± 1.0   2.2  ± 0.4  2.1 × 105  
DR TrxR M84F,K173R/EC Trx1 4.7 ± 0.8 1.3 ± 0.2 2.8 × 105  
DR TrxR M84F,K173R/DR Trx1 16.5 ± 1.5 0.9 ± 0.1 5.4 × 104  
 
Table 3.7: Kinetic parameters DR TrxR double mutant (M84F, K137R). The double mutant has 
a higher Km value for DR Trx1 double mutant than EC Trx1, demonstrating a switch in 
specificity. 
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CHAPTER FOUR: CONCLUSIONS AND PERSPECTIVES 
4.1 CONCLUSIONS 
 
Intermolecular forces are the major determinants in many biological processes. These forces play 
an important role in many processes that require specific recognition such as signal transduction, 
regulation, immune recognition and adhesion. They are also important in other biological 
processes such as nucleic acid folding, protein folding and catalysis. A major research goal over 
the years has been to develop an approach which can computationally determine free energies for 
non-covalent interactions in complex molecules (Massova & Kollman, 1999). As a result various 
approaches have been developed that can calculate the effect of mutations on the binding free 
energy of specific protein-protein complexes (Guerois et al, 2002; Huo et al, 2002; Kortemme & 
Baker, 2004; Massova & Kollman, 1999; Sharp, 1998). These computational protocols use 
different energy functions, but there is good agreement among them (Kortemme et al., 2004). 
Previous studies have shown that proteins can be computationally designed to bind new ligands 
(Looger et al, 2003), proteins (Kortemme & Baker, 2004), and nucleic acids (Ashworth et al, 
2006). Using the EC TrxR-Trx complex structure as a guide and site-directed mutagenesis, the 
DR TrxR’s substrate specificity has been successfully altered. First, the residues that enable 
bacterial TrxR to recognize and discriminate between cognate Trxs and Trxs from different 
species were identified (Figure 4.1). Then the role of these residues was validated by the 
successful design of TrxR mutants that exhibited altered specificity for Trx. The DR TrxR 
double mutant (M84F, K137R) showed a higher affinity for EC Trx than DR Trx.  
Understanding the basis of TrxR-Trx interactions provides a framework for design of Trx 
systems with desirable efficiency and selectivity for application in pharmaceutical and 
biotechnological industries. In particular, understanding the basis of the presumed cross-
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interaction between secreted H. pylori Trxs and host proteins (mucins and immunoglobulins) has 
a huge therapeutic potential. HP Trx is thought to mediate catalytic reduction of human 
immunoglobulins and hence facilitates immune evasion.  It has also been proposed that H. pylori 
gains access to the impenetrable gastric mucous layer by using secreted HP Trx to reduce the 
disulfide bonds present in the cysteine-rich mucin regions that are responsible for cross-linking 
mucin monomers. Disruption of secreted HP Trx-host protein interaction may result in 
restoration of the viscoelastic and hydrophobic protective properties of mucus (Windle et al., 
2000). 
 
 
Figure 4.1: Computational alanine scanning mutagenesis results from Roberta Server using (EC 
TrxR-Trx complex structure) showing important residues for interface stability from EC TrxR. 
Calculated change in ∆∆G upon mutation of Trx-binding residues to alanine. The higher value of 
∆∆G signifies a higher contribution of that residue to interface stability. Equivalent residues from 
DR TrxR were identified and experimentally validated as important for interface stability. 
 
 
 
 
 
113 
 
  
4.2 FUTURE DIRECTIONS 
 
Trx-TrxR interactions are side chain mediated protein-protein interactions. We have 
demonstrated that a computationally designed DR TrxR mutant can switch specificity for Trx. It 
would be informative to prepare DR Trx (or any other bacterial Trx) mutants that have altered 
specificity, using similar computational and experimental strategies. Using the Robetta server the 
following E. coli Trx residues are predicted to contribute most to interface stability: W31, M37, 
R73, and I75 (Table 4.1). Of these, only one is invariant W31 (DR Trx W60). The rest are not 
conserved or contain conserved substitutions (Figure 4.2). Therefore an opportunity exists to 
alter specificity through site-directed mutagenesis. The ultimate goal is to design Trx systems 
with desirable specificities and efficiencies for application in various industries.  Catalytic 
efficiency of the fastest enzymes (e.g. catalase) is more than 1000 fold higher than bacterial 
TrxR; therefore an opportunity exists to design TrxR systems with much higher catalytic 
efficiencies than the wild type enzymes. Along with other properties such as heat stability, 
enzymes so designed will be more efficient in industrial and pharmaceutical applications. 
 
 
 
 
 
 
 
 
 
114 
 
  
 
 
 
 
 
 
Figure 4.2: Amino-acid sequence alignments of Trxs from various prokaryotic and eukaryotic 
sources. Invariant residues are highlighted by a red background. TrxR-binding residues are 
underline by blue triangles. 
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Residue # Amino acid type 
E .coli Trx1 
Amino acid type 
D. radiodurans Trx1 
∆∆G (Complex) 
kcal/mol 
31 W W 2.74 
32 A A -0.57 
37 M V 1.04 
41 I V 0.36 
44 E E 0.05 
60 I V 0.67 
72 I V 0.11 
73 R R 2.54 
75 I V 1.10 
77 T T 0.00 
91 V V 0.47 
95 S Q -0.01 
96 K K 0.34 
98 Q A 0.06 
 
Table 4.1: Computational alanine scanning mutagenesis results from Robetta server using the 
EC TrxR-Trx complex (PDB code: 1F6M). Hot spot residues are highlighted in blue. Hot-spot 
residues can be defined operationally as those for which alanine mutations have destabilizing 
effects on ∆∆G of more than 1 kcal/mol. 
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APPENDIX 
A) CHARACTERIZATION OF THIOREDOXIN­THIOREDOXIN REDUCTASE 
INTERACTIONS BY ISOTHERMAL TITRATION 
A1: Introduction 
 
Calorimetry is the principal source of thermodynamic information, because virtually all chemical 
and biological processes are accompanied either by liberation (exothermic reaction) or 
absorption (endothermic reaction) of heat. Isothermal titration calorimetry (ITC) is a calorimetric 
method designed to measure small amounts of heats generated by interactions between two 
reactants in a liquid solution at constant temperature (Pierce et al, 1999; Saboury, 2004). An ITC 
experiment can determine the affinity constant (Ka) between two interacting molecules, and the 
associated thermodynamic parameters: the change in enthalpy (ΔH), the change in entropy (ΔS), 
the change of Gibbs free energy (ΔG), and the reaction stoichiometric index (n). In addition, if 
the ITC experiments are performed at different temperatures the variation in heat capacity (ΔCp) 
can be obtained as well (Bundle & Sigurskjold, 1994; Pierce et al, 1999).  
ITC is universally applicable to all reactions regardless of the chemical nature or size of the 
interacting components. Moreover there is no chemical modification or immobilization needed 
for an ITC experiment. It has thus been widely used to study macromolecule interactions 
(protein-ligand, protein-protein, and protein-nucleic acid interactions) (Cooper, 1999; Pierce et 
al, 1999; Weber & Salemme, 2003). Figure A1 below shows the basic design of an ITC 
instrument. 
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Figure A1: Basic design of an ITC instrument. There are two cells in the adiabatic jacket: the 
reference cell and the sample cell. A small continuous power is applied by the heater on the 
reference cell. Injection of ligand into the sample cell leads to interaction between the ligand and 
macromolecule. Depending on the nature of the interaction, heat is either taken up or evolved. 
Thermopile/thermocouple detectors sense temperature differences between the sample and 
reference cells. The feedback circuit then either increases or decreases power to the sample cell 
to maintain equal temperature with the reference cell. The heat per unit time (µJ/sec) supplied to 
the sample cell is the observable signal in an ITC experiment and is proportional to the heat 
evolved on binding of a ligand to a macromolecule (Pierce et al, 1999). 
 
In a typical ITC experiment, the sample cell is filled with a macromolecule in an appropriate 
buffer and stirred to ensure good mixing. The reference cell is filled with the same buffer used 
for the sample cell. For measurements of binding constants, concentrations of macromolecule 
and ligand should be accurately determined. In addition the final concentrations desired should 
be carefully selected. A good approximation is to make the final macromolecule concentration at 
least 10 times the expected binding constant, and the final ligand concentration to be two times 
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the concentration of the macromolecule. Choice of buffer is also critical when planning an ITC 
experiment. Buffers with low enthalpy of ionization are desired e.g. phosphate buffers (Maley & 
Hassler, 2004; Pierce et al, 1999). Several small volumes of the ligand are injected and changes 
in thermal energy due to association are detected and recorded. The raw data obtained is power 
versus time for each injection. A sample thermogram is shown in Figure A2. 
 
Figure A2: An ITC thermogram of titration of RNase with 3’ CMP. Raw data obtained for 25 
injections of 4 µL of 3’ CMP solution (13mM) into a sample cell containing 1300 µL RNase 
solution at 0.6mM. The reaction was carried out in a filtered and degassed 200mM potassium 
phosphate buffer pH, 5.5. 
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A2: Materials and Methods 
 
The ITC measurements were performed on a CSC ITC-4200 calorimeter at the SSSC. Purified 
EC TrxR and EC Trx were dialyzed against the reaction buffer (100 mM potassium phosphate 
buffer, pH 7.5) at 4ºC and degassed by stirring under vacuum for 10 minutes just before titration. 
Various EC Trx concentrations (1000-2000 µM) were injected (15-20 injections of 10µL using a 
250µL Hamilton syringe) into sample cell containing 1.30 mL of EC TrxR solution (10 µM). 
The sample cell was continuously stirred at 300 rpm with 3 minutes between injections. 
A3: Results and Discussion 
 
Currently two spectrophometric assays (insulin reduction and DTNB reduction assays) are 
popularly used two characterize interactions between TrxR and Trx. The two assays are 
relatively easy and cheap, however, they have some limitations; for example, DTNB inactivates 
rat TrxR in the presence of Trx (Luthman & Holmgren, 1982), and HP TrxR reduces insulin 
even in the absence of thioredoxin (Pervin, 2006). Moreover, evaluating protein-protein 
interactions using Michealis-Menten kinetics involves the assumption that the rate of product 
formation and release is much slower than that of substrate binding (k2 << k-1) as discussed in 
section 1.3.1. It has been shown that the rate of product formation (domain rotation during 
catalysis) is the slowest step in the reaction (Lennon & Williams, 1997), however, it is not clear 
if the difference is large enough for Km ൎ k-1/k1, the dissociation constant. ITC thus offers an 
attractive alternative to spectrophotometric assays in characterizing the TrxR-Trx interactions. 
Using ITC, it is possible to characterize interactions between TrxR and Trx under reducing 
(presence of NADPH) and non-reducing conditions. It is also possible to characterize the 
interaction between the wild-type enzyme and active-site mutants. The EC TrxR C138S active 
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site mutant is predicted to be predominantly in the FO conformation, whereas the wild type 
enzyme has been shown to be predominantly in the FR conformation. It would be interesting to 
see if there is any interaction with the FO favoring mutant, even though the active site disulfide 
is buried and unavailable for catalysis. Although it requires a large amount of samples, ITC thus 
offers huge advantages over spectrophotometric assays in characterization of TrxR-Trx 
interactions. 
A unitless parameter, the Wiseman constant, has been widely used to predict the success of an 
ITC experiment. This parameter can be calculated by the equation below: 
 
                                                          c = [M]Ka 
 
Where [M] is the concentration of the macromolecule and Ka is the association constant. The 
best thermodynamic data is obtained by those systems with a Wiseman constant of 10 ൑ ܿ ൑
 Daranas, 2003; Wiseman et al, 1989). For the EC Trx system (assuming the Kd 
to be approximately the same as the Km), a macromolecule concentration of 10µM would give a 
Wiseman constant of 5 (close to the recommended range). The ITC experiment was carried out 
as described in section A2. At this concentration of TrxR there was a low signal to noise ratio. 
Moreover, it was not possible to reach saturation because of an endothermic to exothermic 
conversion at approximately a 1:1 TrxR:Trx stoichiometry, possibly because of an exothermic 
conformational change (Figure A3). 
500 (Turnbull &
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Figure A3: An ITC thermogram of titration of EC TrxR with EC Trx1. Raw data obtained for 15 
injections of 10 µL of EC Trx solution (2.0 mM) into a sample cell containing 1300 µL EC TrxR 
solution at 10 µM. The reaction was carried out in a filtered and degassed 100mM potassium 
phosphate buffer, pH 7.5. 
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B) CRYSTALLIZATION OF HP TRX1 AND HP TRX2 
B1: Introduction 
 
As discussed in section 1.1.4, H. pylori contains two Trxs. The two Trxs show relatively low 
primary sequence identity to one another (35% sequence identity). Trx1 has the highly conserved 
Trx active site motif, CGPC, found in most Trxs whereas Trx2 has an unusual motif, CPDC, not 
found in other Trxs. In addition, Trx2 has an unusually high pI (8.8) compared to Trx1 (pI 5.3). 
These differences suggest that the two Trxs are functionally dissimilar; which is perhaps an 
essential divergence in roles because of the absence of glutaredoxin system in H. pylori (Baker et 
al, 2001a). Kinetic characterization (Table B1) also suggests some differences.  HP Trx1 has a 
much higher catalytic efficiency compared to HP Trx2 (Table B1) (Pervin, 2006). Determining 
the structure of the two Trxs was attempted in order to thoroughly understand how they differ 
and how they function. 
 
 
    Substrate 
 
 
      Km (µM) 
 
          
Vmax (µM/min) 
 
 
     kcat (s-1) 
 
     
    kcat / Km 
     (M-1s-1) 
  H. pylori 
       Trx1 
 
   25.14 ± 5.60 
 
   7.50 ± 0.83 
 
  17.86 ± 3.75 
 
  7.1 x 105 
 H. pylori 
       Trx2 
 
   26.02 ± 3.96 
 
    0.78 ± 0.10 
 
   1.86 ± 0.41 
 
  7.0 x 104 
 
Table B1: Kinetic constants for H. pylori Trx system using both H. pylori trx1 and H. pylori trx2 
as substrates for HP TtxR. 
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B2: Materials and Methods 
 
HP trx1 and HP trx2 were purified as described in sections 2.2.1 and 2.2.2 respectively. The 
purified proteins were then crystallized by vapor diffusion and microbatch methods. 
B2.1: Crystallization of HP Trx1 
 
Initial broad screening was done by vapor diffusion using commercial broad screens (Qiagen) at 
20ºC but did not yield any crystals. Further broad screening by microbatch at 4ºC, yielded small 
needle-like crystals under the following conditions: 15% PEG 3350 and 0.2M sodium acetate 
buffer pH 4.6. Grid screening and use of additives did not improve the quality of the crystals. 
B2.2: Crystallization of HP Trx2 
 
Initial broad screening for H. pylori Trx2 was also done by vapor diffusion using commercial 
broad screens (Qiagen) at 20ºC. One condition (3.0M ammonium sulfate, 10% glycerol) from the 
ammonium sulfate broad screen yielded crystals. Grid screening and additive screening were 
performed based on these results to find the optimal growth conditions. The best condition was 
found to be 200 mM sodium acetate buffer (pH 5.0), 3.0M ammonium sulfate, and 10% glycerol 
(Figure B1). Spermine (200mM) and glycine (200mM) seemed to be the best additives, i.e. they 
improved the shape of the crystals.  
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A)                                                                          B) 
Figure B1: HP Trx2 crystals (before (left) and after (right) optimization). Crystals before 
optimization were small (0.1mm x 0.1mm x 0.2mm). After optimization the size increased to 
(0.3mm x 0.3mm x 0.4mm). 
B3: Results and Discussion 
 
The initial crystal screening for x-ray diffraction of crystals was done on beamline 08-1D.1 using 
Mar225CCD detector at the Canadian Light Source. HP Trx2 crystals from the optimized 
conditions (from grid screening and additive screening) showed diffraction spots to 4 Å (Table 
B2). Attempts were made to improve diffraction by dehydration and temperature annealing. For 
dehydration, 4µL of a super saturated solution of ammonium sulfate with 10% glycerol were 
added to Trx2 crystals and equilibrated against 100µL of the same dehydrating solution (sitting 
drop) overnight at 4°C before diffraction. Two temperature annealing methods were attempted 
on these crystals. The first attempt was made by blocking the cryo-stream for a few seconds and 
then cooling the crystal in the cryo-stream stream again. Another attempt was made by removing 
the crystal from the cryo-stream and placing it on the cryo-condition before re-looping it. None 
of these attempts improved diffraction.  
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Temperature (K)    100K 
Wavelength (Å)    1.4 
Space Group                 P3 
Unit Cell parameters (Å)   a= 80, b= 80, c= 571 
                 α=β=90, γ=120 
Resolution limits (Å)                         50-4  
 
 
Table B2: Data collection statistics for HP Trx 2 
 
HP Trx1 crystals poorly diffracted (weak powder-like diffraction). Temperature annealing was 
used to try and improve diffraction, but diffraction did not improve. 
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